Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,14658,262,0.99 [0.49-2.00],0.9700337670737168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,14270,256,0.84 [0.66-1.06],0.1476549853646516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,16705,317,0.84 [0.70-1.01],0.0663415438529562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,14169,257,1.09 [0.78-1.53],0.6149691692878666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,16584,314,0.89 [0.74-1.06],0.1950363794110212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,16705,317,0.99 [0.85-1.16],0.9346916591404448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,14649,262,1.02 [0.94-1.11],0.6098672555784623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,14169,257,0.95 [0.79-1.15],0.6238709053166309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",16426,308,1.05 [0.93-1.19],0.4321027457949769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",14373,259,0.95 [0.80-1.14],0.5908640989015311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",14631,263,0.92 [0.80-1.05],0.226679433569495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,16591,314,1.32 [0.92-1.91],0.1353456455818185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,14649,262,1.18 [0.77-1.79],0.4484785541204426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,16478,312,1.18 [0.99-1.41],0.0697588034799795
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,14339,253,1.26 [0.89-1.78],0.1941828907600291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,14571,263,0.96 [0.87-1.07],0.4704764135062373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,16771,321,1.02 [0.84-1.24],0.8252748370969228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,14204,254,0.82 [0.62-1.09],0.171548997270539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,16887,323,1.47 [1.10-1.95],0.0086211266031197
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,16907,321,1.04 [0.90-1.21],0.5776291355566561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,14583,261,0.90 [0.67-1.23],0.5141357662280601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,14204,254,0.94 [0.82-1.07],0.3233791742608677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,14169,257,0.75 [0.51-1.10],0.1421080828819262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",16478,312,1.08 [0.86-1.35],0.5094499472893731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,14169,257,1.24 [1.03-1.49],0.0261465764413626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,16485,311,0.96 [0.69-1.32],0.7905330630532981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,16607,316,1.38 [0.95-2.02],0.0911766580614177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,16771,321,1.15 [0.98-1.35],0.0833067849157767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,14169,257,1.13 [0.91-1.40],0.2576158968962941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,14287,253,0.90 [0.75-1.09],0.2770003991294019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,16954,324,0.85 [0.64-1.12],0.2455031900664756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,16719,318,1.01 [0.80-1.27],0.919739995644687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,14204,254,0.94 [0.64-1.38],0.7587654192501019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,16478,312,0.96 [0.69-1.33],0.8166052976051359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,16635,316,1.10 [0.83-1.44],0.5197784136400248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,16954,324,0.98 [0.74-1.30],0.8922297751833663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,16880,323,1.15 [0.81-1.62],0.4443939628461978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,14571,263,1.19 [0.80-1.76],0.3831962439522421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,14204,254,1.29 [0.91-1.83],0.1585589562293177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,16991,324,1.16 [0.77-1.76],0.4812026065839534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,16705,317,1.07 [0.84-1.36],0.5957808948735407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,16478,312,1.11 [0.84-1.46],0.4704373459450148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,14204,254,1.19 [0.84-1.67],0.3256841821315577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,16846,321,1.09 [0.87-1.35],0.4630541438623117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,14647,266,1.33 [0.95-1.87],0.0954352930251871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,14270,256,0.74 [0.44-1.22],0.2359701917840034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,14631,263,0.77 [0.57-1.03],0.0821464640448764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,16426,308,0.88 [0.63-1.23],0.4585856103612145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,14339,253,0.83 [0.70-0.99],0.0354172124671339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,16607,316,1.08 [0.80-1.45],0.6087231417393457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,14339,253,1.35 [1.00-1.82],0.0492057196922178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,14571,263,1.10 [0.89-1.37],0.3892726775845261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,16845,315,1.10 [0.77-1.56],0.6072097287498751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,16930,323,1.06 [0.77-1.45],0.7306959330700034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,14631,263,1.09 [0.70-1.69],0.7066792583330371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,16705,317,1.08 [0.97-1.21],0.1353257710529855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,16771,321,0.78 [0.54-1.13],0.1822332355795773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,14190,256,1.04 [0.88-1.22],0.6658012788067982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,14339,253,1.03 [0.88-1.22],0.6848249075853463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,16478,312,1.14 [1.00-1.29],0.0417819847052433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,14658,262,0.90 [0.76-1.06],0.2090419472761044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,16938,322,1.10 [0.75-1.62],0.6257297641792267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,14169,257,1.09 [0.93-1.28],0.3009440934797499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,14339,253,1.07 [0.92-1.23],0.3783878834607952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFM,Afamin,14658,262,1.13 [0.63-2.03],0.6727789294802771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,16583,316,0.99 [0.84-1.15],0.8609093169883941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,14190,256,0.97 [0.85-1.10],0.6318414345289214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,16737,313,0.92 [0.72-1.18],0.5168822445581178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,16270,316,1.09 [0.99-1.21],0.0826042450586765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,16390,307,0.91 [0.76-1.08],0.2725249162395263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,16845,315,1.28 [0.96-1.69],0.0902160337244076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,16954,324,0.99 [0.82-1.20],0.9538662604290418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,14649,262,0.88 [0.52-1.50],0.6416926207835367
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,16771,321,1.04 [0.91-1.19],0.5910876895021302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,16771,321,0.94 [0.81-1.08],0.375768783843541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,14270,256,0.73 [0.49-1.10],0.1363982767771235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,14270,256,1.10 [0.75-1.61],0.6207265405656095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,14583,261,1.02 [0.85-1.22],0.8316525767725388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,14649,262,1.31 [0.85-2.02],0.2230533321702159
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,16764,321,0.91 [0.81-1.03],0.1335941049093604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",14258,257,1.03 [0.90-1.18],0.6459854122476731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,16426,308,0.88 [0.72-1.07],0.1918682921999639
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,14270,256,0.99 [0.79-1.24],0.9313793191456328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",16679,315,1.01 [0.92-1.11],0.7659499436904829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,16771,321,0.83 [0.71-0.97],0.0206497398837495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",14621,264,1.02 [0.91-1.14],0.7858729853982442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,14339,253,0.92 [0.50-1.66],0.7710299331009511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,16426,308,0.95 [0.83-1.09],0.4818561868668283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,14258,257,1.23 [1.04-1.46],0.0167141980576615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,16478,312,0.97 [0.79-1.19],0.7500645793271093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,14204,254,1.09 [0.92-1.30],0.3312133045514672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,16402,318,0.92 [0.80-1.08],0.3104223043113339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,14613,264,0.97 [0.89-1.07],0.5626896850585512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,16359,308,1.01 [0.85-1.21],0.8987877010331762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,16991,324,1.28 [0.77-2.12],0.344019620405111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,16799,321,0.88 [0.72-1.06],0.1748949580296211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",14583,261,1.02 [0.81-1.28],0.897318535371928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",16709,318,1.09 [0.95-1.24],0.2126566621481048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",14613,264,0.96 [0.74-1.25],0.768769386366278
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,14373,259,0.90 [0.68-1.21],0.4946688657683491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,14204,254,1.05 [0.95-1.15],0.36242434732254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",16705,317,1.10 [1.00-1.21],0.0608478424643804
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,16485,311,1.03 [0.71-1.49],0.875659604247077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,16910,322,1.38 [0.85-2.23],0.1870775694343946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,14647,266,1.07 [0.67-1.69],0.7791304558546401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,16402,318,1.02 [0.87-1.20],0.805991850821294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,14258,257,1.00 [0.79-1.28],0.986108847764541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,16705,317,1.06 [0.69-1.62],0.7999419494302815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,16485,311,1.28 [1.04-1.56],0.0193435425160925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,14339,253,1.42 [1.04-1.94],0.0257475945328055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,14523,258,1.03 [0.80-1.31],0.8364031127544974
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,14621,264,0.89 [0.75-1.04],0.1502450563991939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,13680,243,0.98 [0.76-1.25],0.8612432910512782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,16120,311,0.98 [0.79-1.20],0.8111750687805693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,15643,302,1.00 [0.81-1.23],0.9723124312053422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,16778,321,1.38 [1.03-1.85],0.0287657494035791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,16702,313,0.98 [0.87-1.10],0.6771036154849814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,16938,322,1.21 [0.93-1.56],0.1505609502528786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,16543,315,1.18 [0.84-1.67],0.341977021844672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,16791,315,1.04 [0.81-1.34],0.757488742353877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,16816,321,0.81 [0.61-1.06],0.1266974236195866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,16820,315,1.21 [0.97-1.52],0.0897433058710954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,16938,322,1.16 [0.88-1.53],0.2971684783316562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,14169,257,1.05 [0.90-1.24],0.516251408095536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,14204,254,1.00 [0.86-1.17],0.9685644243155092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,14130,252,1.07 [0.86-1.32],0.5409947783816391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,16426,308,0.84 [0.70-1.02],0.0834802140295697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,14270,256,0.75 [0.52-1.08],0.1253510246780506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,16854,320,1.06 [0.74-1.53],0.7394363020141885
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,14263,252,0.86 [0.63-1.17],0.3453261177186186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,16402,318,1.09 [0.97-1.22],0.1369963656274873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,16719,317,0.90 [0.78-1.04],0.1624373515182122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,14048,252,1.09 [0.92-1.29],0.3150313632010518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,16880,323,0.95 [0.83-1.10],0.4941344757545024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,16699,320,0.92 [0.80-1.06],0.2290697434467281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,16350,316,1.13 [0.81-1.56],0.4710728954786601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],16485,311,0.95 [0.79-1.15],0.623929635275616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,16877,322,1.27 [0.91-1.77],0.166107425242195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,14583,261,0.97 [0.84-1.13],0.7323174759534925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,14258,257,0.95 [0.74-1.23],0.7044874457879229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,14571,263,0.94 [0.81-1.10],0.4693881189634873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,14621,264,1.00 [0.78-1.28],0.9993015623633148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,16705,317,0.87 [0.69-1.11],0.2600009587859266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,14510,262,1.04 [0.73-1.50],0.8192832832068302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,16878,321,0.94 [0.79-1.11],0.4601979800958262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,16771,321,0.97 [0.80-1.18],0.7535868242246797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,14658,262,1.00 [0.64-1.57],0.9885189573335978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,14649,262,1.15 [0.91-1.45],0.255149143652578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,14658,262,1.26 [0.91-1.74],0.1630811011770347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,14649,262,1.14 [0.68-1.90],0.6269166132959136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,14270,256,0.83 [0.63-1.10],0.1931072195040775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,14631,262,0.80 [0.57-1.11],0.1752396075855656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,14027,253,0.83 [0.59-1.16],0.273546192399841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,14658,262,1.05 [0.89-1.24],0.5677092103956902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,14649,262,0.71 [0.46-1.10],0.124081629975137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,16799,321,0.94 [0.72-1.23],0.6634667284244715
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,14649,262,0.95 [0.75-1.19],0.641574472244979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,16846,321,0.74 [0.53-1.04],0.0828832456595454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,16782,320,0.92 [0.79-1.07],0.2724743704266406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,14339,253,0.96 [0.86-1.07],0.4468332650641291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,16602,316,0.91 [0.74-1.12],0.3512991152132984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,14373,259,0.91 [0.76-1.09],0.3119132814404174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,16705,317,1.23 [0.98-1.56],0.0786155588262817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,14571,263,0.95 [0.85-1.05],0.3136053420520546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,14613,264,0.92 [0.77-1.10],0.371557347429583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,16698,317,0.82 [0.68-1.00],0.0452024528890175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",14583,261,0.84 [0.62-1.14],0.2596279947223434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,16426,308,0.81 [0.65-1.01],0.0605225916881053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,16426,308,0.91 [0.77-1.09],0.3053842177833667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,14373,259,0.93 [0.68-1.28],0.6662267817557139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,14339,253,0.97 [0.83-1.13],0.6818495340783066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,14130,252,1.08 [0.93-1.25],0.2971542261154555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,14621,264,0.99 [0.87-1.13],0.9020126899528904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,14613,264,0.99 [0.87-1.12],0.8556274074904691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,16744,318,1.00 [0.91-1.10],0.9961685853755364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,14190,256,1.02 [0.86-1.20],0.8267558190730268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,14190,256,0.95 [0.70-1.29],0.7614573397513759
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,16402,318,0.74 [0.55-0.98],0.0380988571760228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,14169,257,1.11 [0.95-1.31],0.1972431966478815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,14169,257,0.90 [0.66-1.22],0.5088699653293612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,14190,256,0.95 [0.77-1.17],0.6257986310926988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,16485,311,0.97 [0.72-1.29],0.8192338988724726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,14169,257,1.00 [0.79-1.25],0.9721447629676468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,16799,321,1.06 [0.85-1.32],0.621419623986117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,16705,317,0.94 [0.78-1.13],0.5080078043917321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,16877,322,0.87 [0.66-1.14],0.3132489321823637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,14190,256,0.90 [0.73-1.11],0.3302581943255712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,16485,311,1.14 [0.94-1.40],0.1873071451256001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,14498,264,1.08 [0.83-1.39],0.5728546279113768
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,16635,316,1.00 [0.83-1.20],0.96564442899084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,16635,316,1.46 [1.06-2.00],0.0188310281416291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,14649,262,1.65 [1.09-2.52],0.0192671103318417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,14631,263,1.11 [0.75-1.65],0.5978761438490732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,14613,264,0.94 [0.79-1.13],0.5196512698159086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,14270,256,0.97 [0.86-1.09],0.626420529795537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,14169,257,1.01 [0.86-1.18],0.9062122706910012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,16402,318,1.00 [0.86-1.16],0.9648478566481145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,14130,252,1.00 [0.70-1.43],0.9922555801861768
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,14571,263,0.99 [0.86-1.14],0.8668663625638479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,16426,308,0.81 [0.67-0.96],0.017264390211489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,16846,321,0.91 [0.79-1.05],0.1817418743203298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,14169,257,1.04 [0.81-1.33],0.7866604225171523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,14169,257,0.83 [0.57-1.23],0.3565303544354445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,14169,257,1.06 [0.78-1.43],0.7060321463890731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,14130,252,1.07 [0.81-1.41],0.6277260828646569
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,14169,257,0.98 [0.80-1.20],0.8407393849375271
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",14169,257,1.19 [1.00-1.43],0.0517772657106875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",16845,315,0.96 [0.87-1.05],0.3211648234865763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",16402,318,1.22 [0.99-1.50],0.0610439734124058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,16426,308,1.08 [0.85-1.38],0.5244237946648838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,16705,317,0.58 [0.38-0.87],0.0094801482337469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,16373,318,0.95 [0.82-1.11],0.5374107190546968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,14270,256,0.86 [0.72-1.02],0.0859711579500041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,14169,257,1.02 [0.90-1.16],0.7218636903002209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,14571,263,1.19 [0.82-1.70],0.3582229946209475
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",14658,262,0.92 [0.45-1.87],0.8183946653306395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,16402,318,1.01 [0.88-1.17],0.8471969881212842
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,14190,256,1.03 [0.92-1.14],0.5995079021518585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,14613,264,1.37 [1.12-1.68],0.0022197298188638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,14621,264,0.86 [0.71-1.05],0.1332566857478841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,16744,318,1.00 [0.90-1.11],0.9470954658482076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,16877,322,0.92 [0.64-1.32],0.639554495218301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,14613,264,1.03 [0.83-1.28],0.7883043261897005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,16268,313,0.84 [0.73-0.98],0.0217951842878302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,14658,262,1.01 [0.69-1.47],0.977426418160574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,14169,257,0.44 [0.24-0.82],0.010213266335032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",14270,256,0.92 [0.66-1.27],0.6109319061083167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",16845,315,1.42 [1.00-2.04],0.052708064603742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",16799,321,0.99 [0.66-1.50],0.9682376301658784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,14204,254,0.81 [0.52-1.27],0.3572229623843055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,16744,318,0.98 [0.85-1.12],0.7207651443451822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,16607,316,1.01 [0.79-1.30],0.9124010189688694
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,14204,254,1.05 [0.82-1.34],0.7180290598281266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,16478,312,0.96 [0.72-1.27],0.7706689666392089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,16426,308,0.99 [0.84-1.16],0.890438231327252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,16426,308,0.99 [0.69-1.41],0.9451258702974246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,16744,318,0.99 [0.91-1.09],0.9119154566686782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,14621,264,1.01 [0.85-1.19],0.953089534259926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,14258,257,0.91 [0.78-1.07],0.2570470923123611
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,16378,317,0.94 [0.84-1.05],0.2693144123944625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,16799,321,0.82 [0.54-1.25],0.359973705807402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,16635,316,0.84 [0.63-1.12],0.2422170452941656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",14631,263,0.86 [0.57-1.28],0.4524723696381926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",14190,256,0.79 [0.61-1.02],0.0747098464521248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,14379,261,1.72 [1.09-2.71],0.02024274630177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,14571,263,1.04 [0.84-1.28],0.7408329760197853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,14621,264,0.95 [0.85-1.07],0.4262377886550954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",16744,318,0.96 [0.76-1.21],0.7144878025673426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,14204,254,0.95 [0.76-1.18],0.6459335016945945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,14130,252,0.98 [0.80-1.19],0.8111868885257654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,14583,261,1.11 [0.88-1.41],0.3733465313378895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,16744,318,0.98 [0.88-1.10],0.7510106058597388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,14647,266,0.95 [0.83-1.09],0.4929482981118048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,14270,256,0.90 [0.73-1.11],0.3183817302555777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,14130,252,0.89 [0.66-1.19],0.4189171345482896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,14647,266,0.91 [0.79-1.04],0.1690595599371784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,16393,307,1.02 [0.94-1.12],0.5747532414218675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,14190,256,0.95 [0.80-1.14],0.5976382388880335
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,14169,257,1.04 [0.66-1.64],0.8689387352928337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,16744,318,0.95 [0.82-1.11],0.5191120820773476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,16799,321,0.92 [0.83-1.03],0.167634264708707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,16426,308,0.97 [0.82-1.14],0.6821675984580373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,16991,324,0.85 [0.62-1.17],0.3197835703208136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,14204,254,1.29 [0.96-1.72],0.0867404269586441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,14190,256,1.04 [0.89-1.21],0.6594469787163362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,14621,264,1.06 [0.79-1.42],0.7114425003916502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,16799,321,0.83 [0.72-0.97],0.021268963176604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,14339,253,0.95 [0.62-1.45],0.805083025362386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,16607,316,1.15 [0.93-1.41],0.197992854147141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,16459,312,1.05 [0.82-1.35],0.7102635642492294
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,14339,253,2.13 [1.33-3.42],0.0016356628041593
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,14631,263,0.97 [0.68-1.39],0.8836372535003054
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,14204,254,1.09 [0.83-1.45],0.5303722035604321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,16478,312,1.30 [0.84-2.00],0.2438490532097366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,14190,256,1.00 [0.80-1.26],0.9697800145955418
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,14270,256,0.76 [0.61-0.96],0.0196843060895322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,13768,241,0.99 [0.88-1.11],0.820782146777855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,16743,318,0.97 [0.83-1.13],0.6675256026721347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,14602,263,0.88 [0.73-1.07],0.1967278467515905
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,14436,262,0.96 [0.86-1.07],0.4711159019186919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,14373,259,0.83 [0.55-1.26],0.3739943290397046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,14190,256,0.67 [0.45-1.00],0.047729641257775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,14169,257,0.94 [0.73-1.22],0.6415568911384549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,14169,257,0.82 [0.59-1.14],0.2315511551126426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,16402,318,0.90 [0.72-1.12],0.3456603184933544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,14190,256,0.91 [0.66-1.26],0.5842601863602486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,14613,264,1.20 [0.88-1.63],0.2433419852211794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BSG,Basigin,16928,323,1.41 [0.87-2.28],0.1645203089123053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BSND,Barttin,14130,252,0.76 [0.51-1.13],0.1790798755308082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,16913,324,1.04 [0.84-1.28],0.7464342434984017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,16913,324,1.11 [0.91-1.35],0.2844860758638116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,16426,308,0.98 [0.85-1.12],0.7446096563531576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,14658,262,1.33 [0.74-2.39],0.3402197380170969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,14130,252,1.04 [0.92-1.18],0.5014648337486444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,14553,261,1.04 [0.77-1.40],0.798005845112119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,16845,315,1.21 [0.83-1.74],0.3194945339878139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,16744,318,1.06 [0.82-1.38],0.6654079285673632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,14130,252,0.83 [0.59-1.16],0.2695143374299229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,16402,318,1.13 [0.98-1.30],0.0855392097466437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,14169,257,0.98 [0.67-1.42],0.9002491864394214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,16875,323,1.01 [0.65-1.58],0.9488804581869416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",14613,264,0.99 [0.84-1.16],0.8738149319983188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,14204,254,1.15 [0.87-1.51],0.3267867474616175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,16877,322,1.08 [0.86-1.36],0.4878666266924297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,14339,253,1.23 [0.88-1.73],0.2204143660541552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,14613,264,0.96 [0.67-1.38],0.8351539614225638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,14312,253,0.82 [0.65-1.04],0.0988316513283171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,14658,262,1.48 [0.82-2.69],0.192558744331322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,14627,262,1.94 [1.04-3.62],0.0359547041718096
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,14658,262,1.49 [0.85-2.61],0.1637624936041417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2,Complement C2,16846,321,0.93 [0.60-1.46],0.7622096500777484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,16373,318,0.93 [0.73-1.19],0.5581000532990615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,14258,257,0.93 [0.74-1.15],0.4945027700760591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C3,Complement C3,13892,250,0.96 [0.72-1.28],0.78432480211522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,16846,321,1.18 [0.92-1.52],0.1914632488851067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C5,Complement C5,14658,262,1.67 [0.77-3.64],0.1940218527888167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,14288,260,1.62 [1.11-2.37],0.0121193941667772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,14621,264,1.06 [0.63-1.77],0.8276722300343071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,14658,262,1.01 [0.68-1.49],0.9537326340868876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,14649,262,1.00 [0.81-1.24],0.9815169185973268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,14571,263,0.85 [0.74-0.99],0.0364143885096059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,16460,317,0.80 [0.68-0.95],0.0113873910516324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,16426,308,1.07 [0.78-1.48],0.6701717535991534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,16705,317,1.13 [0.83-1.53],0.442265083933298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,16599,316,0.95 [0.86-1.04],0.2433009947439505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,16938,322,0.89 [0.67-1.17],0.4032078089124223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,16736,321,0.83 [0.72-0.96],0.0129918269192105
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,16969,324,0.97 [0.82-1.14],0.7000875256653596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,16991,324,1.01 [0.68-1.52],0.9430047331699118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",16478,312,1.03 [0.92-1.15],0.6217527265654272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,16745,320,1.01 [0.86-1.19],0.9025360076423496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,14373,259,0.83 [0.57-1.20],0.3160689199299542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,14204,254,0.93 [0.57-1.53],0.78219704007767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,16938,322,1.25 [1.03-1.52],0.0220642736669196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,14258,257,0.97 [0.80-1.18],0.7754601012952894
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,14190,256,0.84 [0.57-1.24],0.3712802268682662
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,14169,257,0.95 [0.77-1.19],0.6808190024036097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,14190,256,0.92 [0.75-1.13],0.439029799045978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,14613,264,0.98 [0.85-1.13],0.78729489082723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,14315,253,0.98 [0.87-1.10],0.7045365688904965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,14258,257,0.95 [0.70-1.29],0.7407490953613067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,16705,317,1.14 [0.91-1.42],0.2524568759217209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,16402,318,0.97 [0.69-1.37],0.867534637344587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,16606,316,1.04 [0.89-1.21],0.6379198186227286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,14621,264,1.19 [0.92-1.54],0.1896670334762067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,16880,321,1.00 [0.91-1.11],0.9247846318230492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,14270,256,0.97 [0.83-1.14],0.7217851244663627
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,14169,257,1.01 [0.74-1.39],0.932487354257463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,16426,308,0.95 [0.75-1.20],0.6627535883911937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,14258,257,1.04 [0.84-1.30],0.7224841859088776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,14613,264,0.97 [0.86-1.08],0.5593200092925288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,16709,319,1.12 [0.69-1.84],0.6401451989719564
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,16668,320,1.08 [0.91-1.28],0.3730854430978502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,14583,261,1.30 [0.98-1.72],0.0700319716866678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,14621,264,1.03 [0.93-1.15],0.557198144984082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,16402,318,0.85 [0.70-1.04],0.1121319863269744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,14258,257,1.02 [0.76-1.36],0.9160690313551172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,16402,318,1.04 [0.90-1.20],0.5897594032143433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,16402,318,1.01 [0.87-1.16],0.9333729511023774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,16744,318,1.02 [0.88-1.19],0.7543602940932674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,16991,324,0.96 [0.86-1.08],0.5190396623087412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,14373,259,1.01 [0.94-1.08],0.8459103394560191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,14621,264,0.97 [0.84-1.12],0.6986028856151836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,16879,321,0.92 [0.78-1.08],0.2929343932187181
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,14204,254,1.07 [0.88-1.30],0.4827906293213171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,14169,257,1.07 [0.85-1.34],0.5723842992000057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CAT,Catalase,14435,257,0.79 [0.63-1.00],0.0495072877390095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,16745,321,1.02 [0.90-1.15],0.7518317787739129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,14190,256,0.96 [0.84-1.11],0.5918221201097202
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,16938,322,1.24 [0.93-1.66],0.1384587018668528
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,14270,256,1.08 [0.86-1.37],0.4919910911255719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,14169,257,0.92 [0.67-1.27],0.6298396947727682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,16635,316,0.92 [0.80-1.06],0.2445396179611216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,14621,264,0.99 [0.80-1.24],0.9597375999319429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,14583,261,1.19 [0.94-1.50],0.1537549811319827
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,14258,257,0.88 [0.58-1.32],0.5322337837141478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,14613,264,0.97 [0.82-1.14],0.6944000386611775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,16771,321,1.12 [0.86-1.46],0.3930350616494936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,14270,256,0.98 [0.80-1.18],0.8052186518470437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,16954,324,1.00 [0.77-1.31],0.9783767620411254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,16927,324,0.89 [0.77-1.03],0.1307456620315112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,16778,321,0.96 [0.74-1.23],0.7265177237408169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,16991,324,1.40 [1.14-1.73],0.0016103243863772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,16991,324,1.05 [0.86-1.27],0.6316642256951036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,16756,315,1.01 [0.90-1.12],0.9055053503732188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,16575,318,0.91 [0.78-1.06],0.2316833481797191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,16913,324,1.02 [0.94-1.10],0.6878342395379351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,16607,316,0.78 [0.65-0.95],0.0141725208294057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,16954,324,1.04 [0.94-1.16],0.4681834703177769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,16845,315,1.09 [0.86-1.39],0.4807967916070803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,16630,314,1.11 [0.91-1.34],0.300227931727399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,16845,315,1.04 [0.82-1.33],0.7258231202189843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,16820,315,0.99 [0.88-1.11],0.8212829584617103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,16954,324,1.13 [0.92-1.38],0.2420982206196147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,16744,318,0.97 [0.87-1.08],0.5731846035650753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,16771,321,1.02 [0.87-1.21],0.7910291666911224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,16679,318,1.08 [0.92-1.28],0.3325074809149223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,16744,318,1.02 [0.85-1.23],0.8187208991939037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,16807,315,0.94 [0.80-1.10],0.4585248440810395
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,16877,322,0.97 [0.88-1.07],0.4921639860914886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,16744,318,0.93 [0.78-1.12],0.4422657315764763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,16910,322,0.88 [0.75-1.03],0.1020194278134206
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,16672,316,1.00 [0.87-1.14],0.9465926563836404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,16761,315,0.89 [0.75-1.07],0.2249169601810612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,16961,323,0.95 [0.70-1.27],0.7140082212714749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,16938,322,1.05 [0.82-1.35],0.7008304796888676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,16799,321,1.03 [0.79-1.33],0.843933795847286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,14373,259,0.94 [0.68-1.31],0.7210718799807687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,14204,254,1.05 [0.93-1.20],0.4099495675100018
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,16635,316,0.83 [0.67-1.02],0.081177747646154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,16426,308,0.89 [0.70-1.13],0.3421798988900022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,14571,263,1.21 [0.93-1.59],0.1574294430541954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,16799,321,1.10 [0.81-1.48],0.5425759876333544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,16496,319,1.31 [1.03-1.66],0.0288728561332538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,16954,324,1.12 [0.91-1.37],0.2862998696460336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,16877,322,1.03 [0.82-1.29],0.8144671099954753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,16799,321,1.47 [1.15-1.88],0.0023893203909656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,14258,257,1.25 [0.93-1.68],0.1431072057430548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,16772,320,1.06 [0.98-1.14],0.1562365669758684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,16846,321,1.13 [0.75-1.69],0.5676096809204766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,14169,257,1.20 [0.93-1.55],0.1576974933281262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,16744,318,0.86 [0.58-1.25],0.4233010571320685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,16691,318,1.14 [0.86-1.50],0.3520409133612168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,16384,312,1.01 [0.78-1.30],0.9680845597994232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,16841,321,0.96 [0.74-1.25],0.7728871763675166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,16954,324,1.06 [0.84-1.34],0.6340766810117513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,14204,254,1.09 [0.82-1.46],0.5532711501018045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,16954,324,1.02 [0.71-1.45],0.9327033520726676
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,14647,266,1.02 [0.76-1.37],0.8817881545480576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,16846,321,1.14 [0.90-1.45],0.2725668560066446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,16635,316,1.34 [1.01-1.78],0.0397383198915766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,16765,314,1.05 [0.79-1.39],0.7291948691310857
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,16426,308,1.09 [0.84-1.43],0.5155513740282769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,16771,321,0.91 [0.78-1.07],0.2468962703640899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,14339,253,1.11 [0.75-1.65],0.5940982703414565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,16913,324,1.27 [0.97-1.67],0.0865996761516728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,16880,322,1.06 [0.83-1.34],0.6447883980843261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,16938,322,1.12 [0.95-1.34],0.1782882852577488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,16799,321,0.80 [0.62-1.04],0.1007776994083341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,16705,317,1.39 [1.02-1.89],0.038520966112717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,16846,321,0.97 [0.86-1.10],0.6582799600218561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,16866,324,1.07 [0.71-1.61],0.7477733511677007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,14204,254,1.15 [0.88-1.50],0.3032433307176563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,16705,317,1.04 [0.76-1.40],0.8212033742422267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,14190,256,0.83 [0.56-1.24],0.3625214430525463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,14373,259,1.08 [0.79-1.46],0.6407201461738512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,14204,254,0.99 [0.86-1.14],0.891819607446448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,16714,318,1.02 [0.73-1.41],0.9182546062382508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,16782,315,0.98 [0.80-1.21],0.8566069448577989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,16954,324,0.94 [0.83-1.07],0.3443928621034486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,16726,319,1.02 [0.72-1.45],0.905934831803871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,16820,315,1.12 [0.80-1.56],0.5156995539847451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,16910,322,1.33 [1.00-1.77],0.0497730147958637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,16220,309,0.96 [0.65-1.40],0.8145475622457592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,16747,313,1.02 [0.58-1.79],0.9489274702285624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,16217,308,1.08 [0.70-1.65],0.7410290923229812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,14583,262,1.05 [0.82-1.35],0.7077263890694251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,16928,323,1.09 [0.91-1.32],0.3536635340427436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,16607,316,0.85 [0.70-1.03],0.1037638794779932
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,16715,321,0.97 [0.87-1.09],0.5946015513092668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,14171,253,1.18 [0.90-1.53],0.2341559203471173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,16744,318,1.04 [0.83-1.32],0.7181384143003127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,14339,253,1.20 [0.90-1.60],0.2114155283146153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,16913,324,1.17 [0.88-1.55],0.2934736107577362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,16954,324,1.11 [0.89-1.38],0.3728869159260781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,14631,263,1.29 [0.91-1.83],0.1553196963451829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,14373,259,1.41 [1.12-1.76],0.0028756790290657
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,16744,318,0.93 [0.69-1.25],0.6417323743901059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,16744,318,0.94 [0.68-1.28],0.6779340234271769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,14571,263,1.00 [0.67-1.51],0.9842333028273312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,16913,324,1.25 [1.04-1.49],0.0178163341773339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,16193,310,1.07 [0.77-1.48],0.6965073559355685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,16799,321,0.90 [0.54-1.49],0.6866492381967573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,16799,321,0.88 [0.58-1.32],0.5275544978010267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,14603,263,0.68 [0.52-0.89],0.0044748885185946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,14621,264,1.38 [0.89-2.13],0.1465996430821601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,14130,252,1.10 [0.92-1.31],0.298454272262581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,14130,252,1.03 [0.76-1.40],0.8494323246459241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,14540,262,0.97 [0.82-1.16],0.767583330019424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,16426,308,0.99 [0.83-1.17],0.8670008953333009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,16846,321,0.94 [0.83-1.06],0.3118691867103926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,14571,263,1.01 [0.90-1.13],0.8951579704340155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,16635,316,1.00 [0.83-1.20],0.9757431036504874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,16254,312,1.19 [0.93-1.52],0.1641598635212333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,16884,324,1.08 [0.94-1.23],0.301121106747915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,16771,321,1.21 [1.05-1.38],0.0064764636080933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,16771,321,1.05 [0.79-1.39],0.7422608998281987
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,14373,259,0.79 [0.51-1.23],0.2925343276599775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,14621,264,1.06 [0.68-1.65],0.8042672507285148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,16913,324,1.16 [0.89-1.51],0.2808040243899387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,14190,256,1.05 [0.82-1.35],0.6700891386353642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,16991,324,1.06 [0.77-1.47],0.717272469590736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,16771,321,1.03 [0.79-1.33],0.8299130936370397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,16402,318,0.97 [0.77-1.24],0.8261347707613705
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,16705,317,1.03 [0.89-1.20],0.672536288801701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,16771,321,1.14 [0.88-1.47],0.321705911710967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,14130,252,1.17 [0.84-1.62],0.3603982349257286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,14613,264,0.77 [0.61-0.96],0.0227353694366151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,14190,256,0.87 [0.68-1.12],0.28897005957369
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,16705,317,1.02 [0.93-1.12],0.6589008755084207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,16705,317,0.94 [0.85-1.04],0.2386690704142549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,16705,317,0.88 [0.65-1.20],0.4316256540388901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,16794,315,1.14 [0.77-1.69],0.5037173902630232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,16902,322,0.95 [0.76-1.19],0.6633668879450896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,16817,319,1.24 [0.75-2.03],0.4012783378347991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,14571,263,0.94 [0.81-1.10],0.4447029879799498
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,14373,259,1.08 [0.93-1.26],0.3064033127781061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,14571,263,0.87 [0.65-1.17],0.3665642837346002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,14373,259,1.03 [0.79-1.34],0.8130998420069031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,16744,318,1.01 [0.90-1.14],0.8249166565118861
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,16426,308,0.83 [0.66-1.05],0.1243318307149761
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,16234,304,1.12 [0.95-1.31],0.1677188959279707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,14647,266,1.01 [0.75-1.36],0.9406000003225816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,16478,312,0.91 [0.74-1.12],0.3844071540541114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,14204,254,1.27 [0.95-1.68],0.1019734739188743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,16478,312,0.87 [0.66-1.14],0.3172866037836339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,14647,266,1.04 [0.86-1.25],0.7143864958219883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,16967,324,1.04 [0.89-1.23],0.614699537720652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,14339,253,0.80 [0.52-1.21],0.2892928096544182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,14204,254,1.17 [0.82-1.68],0.3886637049823778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,14190,256,0.82 [0.64-1.05],0.117883871223943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,14373,259,0.86 [0.68-1.08],0.1831310958340762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,14373,259,1.00 [0.85-1.18],0.9858722917015654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,14169,257,1.09 [0.86-1.39],0.4731740241439013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,14130,252,1.04 [0.79-1.38],0.76985198337441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,16485,311,0.94 [0.79-1.12],0.4599660682965744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,14270,256,0.95 [0.80-1.12],0.5158769341117625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,16426,308,0.95 [0.83-1.09],0.4553096026307551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,14373,259,0.93 [0.74-1.18],0.5675569053330831
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,14130,252,1.05 [0.76-1.44],0.7585356701804105
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,16354,311,0.89 [0.76-1.03],0.1142838047727941
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,16426,308,1.01 [0.86-1.18],0.9327188924389498
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,16402,318,0.88 [0.74-1.03],0.1158227627741215
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,16838,321,1.08 [0.96-1.22],0.1831781824706871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,16705,317,0.93 [0.78-1.12],0.4559554618857209
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,16705,317,1.05 [0.91-1.21],0.4944747108869145
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,16402,318,0.94 [0.81-1.10],0.4410762105241261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,14571,263,0.94 [0.81-1.11],0.4796951772797242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,14402,261,0.93 [0.64-1.35],0.7095797064612899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,16426,308,1.00 [0.80-1.25],0.9959959384796137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,14658,262,0.79 [0.45-1.41],0.4311319361806298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,13802,249,1.21 [0.71-2.06],0.4870272694531448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,14552,260,0.83 [0.69-1.01],0.0660878672166363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,14631,261,1.19 [1.00-1.41],0.043758002298546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,14452,261,1.05 [0.78-1.40],0.7667677055058965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,14658,262,1.39 [0.75-2.56],0.2955354000993158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CFP,Properdin,14658,262,0.94 [0.53-1.66],0.823640513893234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,16799,321,1.16 [1.00-1.35],0.0521374536946763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,14649,262,1.14 [0.83-1.57],0.4240868047377156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,14258,257,0.88 [0.64-1.22],0.4556525522733057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,16771,321,1.22 [0.97-1.53],0.0931194865984816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,16426,308,0.85 [0.71-1.02],0.0759093530465244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,14339,253,0.92 [0.72-1.18],0.5304901642118101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14621,264,1.26 [0.96-1.66],0.0920200528485478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,14583,261,1.31 [0.88-1.93],0.1795801814236046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,16478,312,0.99 [0.73-1.36],0.95993215649001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,14647,266,1.10 [0.98-1.23],0.1203566810674464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,16860,324,0.96 [0.76-1.22],0.745441252757141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,16470,313,1.01 [0.90-1.14],0.8639934813452632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,16874,321,1.01 [0.95-1.07],0.7917464515114788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,16855,321,0.89 [0.64-1.25],0.510808994612673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,14258,257,0.99 [0.81-1.21],0.958190156530366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,16635,316,0.90 [0.79-1.02],0.0905268594951006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,14631,263,0.90 [0.73-1.12],0.3497535411870754
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,14190,256,0.88 [0.73-1.05],0.1484877373036359
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,16820,315,0.95 [0.69-1.30],0.7589954002422837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,16771,321,1.01 [0.82-1.25],0.9068615430479382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,14258,257,0.85 [0.59-1.21],0.3637664760732012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,16846,321,0.89 [0.75-1.04],0.1408100707803334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,14647,266,1.02 [0.82-1.27],0.8547593833291656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,14373,259,1.04 [0.80-1.35],0.7637735851084111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,14571,263,0.95 [0.83-1.07],0.3745049001796184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,14258,257,0.91 [0.69-1.19],0.4727932474220937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,16890,323,1.43 [1.04-1.96],0.0270471002525774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,14647,266,1.01 [0.82-1.23],0.9503421686731756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",16735,313,1.14 [0.97-1.33],0.1033150185991544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,14130,252,0.99 [0.84-1.17],0.903440451087805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,16741,320,0.93 [0.80-1.08],0.3412843525917731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,16635,316,1.09 [0.83-1.44],0.5408535904774837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,16770,321,0.94 [0.77-1.15],0.5294886751787544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,14204,254,2.05 [1.22-3.43],0.0066535404515276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,16799,321,1.18 [0.88-1.59],0.2759742098429333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,16478,312,1.11 [0.83-1.49],0.488115590648316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,16913,324,0.98 [0.88-1.09],0.7044475636242253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,14258,257,0.98 [0.77-1.25],0.8741232771189934
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,14310,261,0.66 [0.37-1.16],0.1492239440555222
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,16744,318,0.72 [0.55-0.95],0.0206291799595469
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,16744,318,1.06 [0.86-1.31],0.5606710442023382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,16744,318,0.93 [0.79-1.09],0.356248042741052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,16744,318,1.24 [0.92-1.68],0.1483556418971299
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,14621,266,0.85 [0.67-1.09],0.2039798587962644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,16734,321,0.90 [0.64-1.26],0.531460950606639
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,16426,308,1.20 [0.97-1.49],0.0971679024850326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,16954,324,1.06 [0.90-1.26],0.4906918903813378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,14258,257,1.06 [0.82-1.36],0.6748792615445751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,14258,257,1.03 [0.70-1.49],0.8967199922808714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,14130,252,1.13 [0.90-1.41],0.2798916143151219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,16744,318,1.03 [0.94-1.12],0.5121159693886279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,16938,322,1.01 [0.64-1.60],0.9517511472730548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,14258,257,0.81 [0.56-1.17],0.2503646959714004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",16606,316,0.96 [0.87-1.07],0.4941311512654724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,16764,321,1.01 [0.88-1.16],0.8612421402208923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,16373,318,1.07 [0.83-1.38],0.5994998659188658
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,16402,318,0.84 [0.68-1.03],0.0895911433581257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,16954,324,1.17 [0.92-1.50],0.1982726613043869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,14621,264,1.56 [1.09-2.23],0.0154157623520594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,16478,312,0.81 [0.65-1.02],0.0795635122924714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,14658,262,1.36 [1.00-1.84],0.0510084261207591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,16743,319,0.97 [0.78-1.22],0.8106756858178488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,14631,263,0.97 [0.85-1.10],0.6031679192257112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,14583,261,0.97 [0.84-1.12],0.7175547907709212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,16877,322,0.94 [0.76-1.16],0.5479443585414503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,14190,256,0.78 [0.60-1.03],0.0818996142661167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",14243,256,0.90 [0.77-1.05],0.1888432271453999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,16478,312,0.89 [0.74-1.07],0.2072976864756596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,16705,317,0.96 [0.84-1.10],0.53367685392113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNST,Consortin,16771,321,0.99 [0.90-1.08],0.7506732342036538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,14190,256,0.97 [0.69-1.37],0.8689393969955226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,16991,324,1.01 [0.70-1.44],0.9711090032149458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,16938,322,1.16 [0.93-1.45],0.1756165827202412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,16799,321,1.40 [1.00-1.98],0.0525673276220779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,16799,321,1.10 [0.73-1.67],0.6427411633720423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,16814,322,0.79 [0.60-1.03],0.0826400204075848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,16744,318,1.06 [0.83-1.34],0.641959370058621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,14258,257,1.06 [0.95-1.18],0.2750342204677548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,14631,263,1.09 [0.85-1.40],0.511320652282762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,14647,266,0.86 [0.56-1.33],0.5007636634910302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,16879,322,1.17 [0.78-1.78],0.4479931452009158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,16991,324,1.00 [0.67-1.49],0.9819505397584684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,14571,263,1.01 [0.81-1.24],0.9572111410373196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,14258,257,1.00 [0.86-1.17],0.9707198730222956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,14270,256,0.95 [0.81-1.10],0.4892075336316859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,14647,266,1.42 [0.86-2.34],0.1675046574846056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,16771,321,1.01 [0.79-1.31],0.9097424508052904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,14348,259,1.00 [0.80-1.26],0.9681821306946524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,14339,253,1.27 [0.94-1.70],0.1164912683910557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,16991,324,1.19 [0.92-1.55],0.1913122402069602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,16744,318,1.08 [0.88-1.33],0.4782053530892513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,14373,259,1.13 [0.89-1.44],0.3088347048869677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,16765,314,1.31 [0.91-1.89],0.1411721999537303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,14270,256,0.94 [0.76-1.15],0.5425002150748233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,14583,261,0.93 [0.68-1.26],0.6441854130004682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,16626,319,0.97 [0.72-1.30],0.8253858977020235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,16314,306,0.97 [0.86-1.10],0.6625912363244992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',14169,257,1.13 [0.87-1.46],0.3536472374529918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,16402,318,0.86 [0.68-1.09],0.2084685007188551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",14270,256,0.90 [0.67-1.22],0.5056194365868556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,16436,312,0.95 [0.84-1.06],0.3525273628303674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,14190,256,1.08 [0.78-1.48],0.6463091268861115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",16705,317,0.91 [0.78-1.05],0.187217161915917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,14631,263,0.93 [0.64-1.34],0.6825163281729579
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,16991,324,1.08 [0.93-1.25],0.3328710556790388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,16861,322,1.14 [0.99-1.32],0.0660319477927415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,14058,249,0.95 [0.71-1.27],0.7313542728715012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,16991,324,1.07 [0.92-1.26],0.3873145656653662
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,14631,262,1.00 [0.59-1.71],0.9968202863529978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,16792,320,0.93 [0.73-1.19],0.5717438053402103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,14130,252,1.09 [0.77-1.54],0.6217370375612797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,16824,324,1.38 [1.03-1.83],0.0282589350539668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",14204,254,1.35 [0.90-2.04],0.1478234825618915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,16913,324,1.04 [0.89-1.21],0.6229780795694821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,14614,266,0.98 [0.70-1.37],0.9150447513219336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,14169,257,0.83 [0.60-1.15],0.2661281990715887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,16916,321,1.08 [0.85-1.38],0.5134979771089814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,16846,321,0.97 [0.84-1.12],0.6790099489853014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,14631,263,1.12 [0.71-1.75],0.6341179488212396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,14597,262,1.12 [0.80-1.57],0.4937451888702873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,16877,322,1.17 [0.95-1.45],0.1346542958168849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,16426,308,0.99 [0.87-1.11],0.8234793748872976
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,16606,316,0.89 [0.78-1.02],0.0834400221780868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,14130,252,1.15 [0.94-1.40],0.1861862155722245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,14130,252,1.10 [0.70-1.74],0.676215408975448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,16592,317,0.85 [0.66-1.10],0.2244766845639259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,14339,253,1.14 [0.82-1.58],0.4435250992307571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,16820,315,1.12 [0.92-1.35],0.259097900937062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,16400,308,0.90 [0.80-1.02],0.1066009984609011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,16765,314,1.33 [0.92-1.92],0.1230212902932576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,16478,312,1.01 [0.86-1.19],0.9035528497776332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,16845,315,1.30 [0.80-2.13],0.2942800867421586
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,16635,316,0.94 [0.72-1.24],0.6819708520104056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,16938,322,0.89 [0.75-1.05],0.174394140316234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,14515,256,0.62 [0.40-0.96],0.0301695542573919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,16802,314,0.99 [0.90-1.09],0.8090677145798029
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,16845,315,1.10 [0.74-1.65],0.6379716106562361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,16351,312,0.98 [0.85-1.14],0.7967914019240572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,16991,324,0.88 [0.64-1.22],0.4492031768882829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,16635,316,1.09 [0.90-1.33],0.3788056994665312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,14258,257,0.90 [0.69-1.18],0.4461233282341322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,16478,312,1.02 [0.93-1.11],0.74060304614575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,14631,263,0.96 [0.80-1.16],0.6816393582653129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,14621,264,0.92 [0.78-1.09],0.3286424054986943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,14621,264,0.98 [0.87-1.11],0.7612821203185715
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,14190,256,1.00 [0.85-1.18],0.9657740722897412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,14270,256,0.91 [0.79-1.04],0.1687232802849084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,14169,257,1.02 [0.92-1.13],0.688444066955952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,16845,315,1.47 [1.02-2.11],0.0367588003006641
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,14649,262,1.07 [0.80-1.44],0.6501510968674158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,14169,257,1.08 [0.78-1.49],0.6562477888712797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,16635,316,1.02 [0.87-1.20],0.7728600979641691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,14204,254,1.08 [0.81-1.44],0.6014249103833831
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,16485,311,1.07 [0.87-1.31],0.529507615968398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,14204,254,1.10 [0.72-1.67],0.6627028944241731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,14649,262,1.10 [0.73-1.64],0.6561427256065815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,14204,254,0.91 [0.74-1.11],0.3484747484303839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,14613,264,0.86 [0.66-1.12],0.2582374856854784
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,14647,266,1.03 [0.72-1.48],0.8575185923288965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,14190,256,0.82 [0.63-1.07],0.1385257104570059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,14169,257,1.17 [1.06-1.30],0.0028642882226343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,12730,217,1.03 [0.91-1.17],0.6024832469408472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,16850,322,1.18 [0.84-1.65],0.340712070495864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,16459,315,0.92 [0.76-1.10],0.333516623088524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,16348,315,1.01 [0.83-1.24],0.8884972591842282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,16807,315,1.06 [0.96-1.17],0.2268567037699729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,16565,320,0.95 [0.75-1.20],0.6389346596938376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,14349,259,1.12 [0.89-1.41],0.3411598887486858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,14425,259,1.04 [0.66-1.64],0.8722976426979161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,16478,312,0.92 [0.82-1.04],0.1973210560460587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,14647,266,1.03 [0.69-1.55],0.8763894989118491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,14647,266,0.99 [0.68-1.45],0.9702853781968714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,14190,256,0.84 [0.57-1.24],0.3773429031623139
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,16799,321,1.13 [0.96-1.34],0.1461995290186384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,16773,314,1.14 [0.98-1.33],0.0814042111943109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,14621,264,1.01 [0.85-1.19],0.9211786417954648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,16823,321,0.96 [0.80-1.16],0.6998788653654034
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,16747,314,0.81 [0.64-1.02],0.0752573394484433
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,15723,295,0.97 [0.75-1.25],0.8241807400314355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,14339,253,1.01 [0.80-1.28],0.9034041333285532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,16846,321,0.90 [0.70-1.16],0.4104603750118024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,16421,312,1.05 [0.92-1.20],0.48551960477263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,16771,321,1.30 [0.88-1.93],0.1892720059247552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,16954,324,1.50 [1.10-2.03],0.0092619716247554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,13138,255,1.35 [0.81-2.25],0.2464725880928452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,16882,320,0.97 [0.77-1.24],0.8267836905763802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,16829,319,1.01 [0.74-1.38],0.9440714624887429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,14258,257,0.82 [0.58-1.17],0.2751351261583253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,14476,260,0.96 [0.79-1.18],0.7250014435819775
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,16635,316,1.00 [0.74-1.35],0.9958014515314264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,16744,318,1.14 [0.94-1.39],0.1876300541604958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,16762,315,1.06 [0.96-1.18],0.2523270475024757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,16845,315,1.10 [0.95-1.28],0.192870183064537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,16913,324,0.90 [0.79-1.02],0.1020680001882818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,16485,311,0.85 [0.66-1.11],0.2318835235059537
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,16913,324,1.04 [0.89-1.22],0.5986528261112147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,16485,311,1.00 [0.84-1.20],0.9706383676703207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,16971,324,0.98 [0.64-1.49],0.906565936228251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,16954,324,1.21 [0.96-1.53],0.0978241037491429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,16782,315,1.05 [0.95-1.17],0.3450606719046953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,16719,319,1.04 [0.95-1.13],0.3861435149021027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,16954,324,1.07 [0.94-1.21],0.3324054696003106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,16691,319,0.99 [0.86-1.15],0.9062319340885856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,16845,315,1.06 [0.91-1.24],0.421460019082721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,14130,252,0.93 [0.77-1.11],0.4016567140008255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,14419,263,1.08 [0.87-1.34],0.4735218787642947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",14169,257,0.99 [0.86-1.14],0.8720585651328765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,14130,252,0.99 [0.84-1.17],0.9424415104251778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,14647,266,0.79 [0.50-1.26],0.3220152067886921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,14339,253,0.96 [0.83-1.11],0.5884484349348644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,16938,322,0.96 [0.88-1.05],0.3314407117374866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,16845,315,1.03 [0.83-1.27],0.8232082560942253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,14204,254,1.13 [0.93-1.39],0.2278394510615441
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,14204,254,1.03 [0.83-1.28],0.8079102432296906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,16744,318,0.98 [0.90-1.06],0.5428323126890051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",16606,316,0.92 [0.81-1.06],0.2601153546981567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,14621,262,0.97 [0.87-1.07],0.5005283063830224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,16728,320,0.93 [0.82-1.06],0.2945448699479174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,14204,254,1.11 [0.87-1.41],0.4144763178455202
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,16845,315,0.97 [0.87-1.08],0.5516457240462265
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",16846,321,1.26 [0.95-1.67],0.1034035936078757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,14258,257,1.03 [0.60-1.76],0.9188511660957084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,14130,252,1.08 [0.90-1.30],0.398927025433662
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,14130,252,1.27 [0.88-1.83],0.2056589217826918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCN,Decorin,16478,312,0.89 [0.58-1.36],0.5903319302624144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,14339,253,0.97 [0.85-1.10],0.6137198889556925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,16938,322,0.90 [0.77-1.05],0.1841051440364818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,16705,317,0.95 [0.85-1.06],0.3817801870987084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,16402,318,0.93 [0.80-1.08],0.3263238614025502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,16771,321,1.15 [0.83-1.58],0.3992396865266164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,14190,256,0.96 [0.81-1.14],0.6413071177953487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,14130,252,0.96 [0.82-1.13],0.6454230971196568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,16846,321,0.98 [0.81-1.18],0.7968447633120067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,14169,257,1.11 [0.83-1.48],0.4998373197157012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",16705,317,1.12 [0.90-1.41],0.3138101038738714
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,16745,321,1.14 [0.93-1.40],0.2129229278530341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,14613,264,0.99 [0.82-1.18],0.892421760583826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,14339,253,0.84 [0.72-0.99],0.0350778671279521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,16913,324,1.26 [0.82-1.92],0.2933955573321885
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,14647,266,0.80 [0.60-1.08],0.1445762673969655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,14571,263,0.92 [0.71-1.19],0.5177867521879538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,14258,257,0.96 [0.69-1.35],0.8247395104105402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,14204,254,1.37 [0.90-2.09],0.139112170055758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,14204,254,1.06 [0.85-1.32],0.6192572521216703
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,14258,257,1.03 [0.74-1.44],0.8406703071588599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,16426,308,0.95 [0.78-1.14],0.5670604304569993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",16744,318,0.97 [0.87-1.07],0.5244906683780852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,16482,319,0.95 [0.78-1.14],0.5655272277482195
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,14087,251,0.84 [0.61-1.16],0.2847960650422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,14190,256,0.86 [0.68-1.09],0.2183778409762247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,14190,256,1.00 [0.85-1.18],0.9789110245505652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,14190,256,0.99 [0.80-1.23],0.9259669755915207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,16562,316,0.98 [0.92-1.05],0.5514310355692402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,14169,257,0.97 [0.75-1.24],0.7982561394042809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,14204,254,0.93 [0.75-1.16],0.5181674035076465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,16954,324,0.93 [0.80-1.08],0.3486492731311899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,14190,256,0.88 [0.65-1.20],0.4306015696136734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,14204,254,1.03 [0.82-1.29],0.7968783644112233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,16485,311,0.96 [0.72-1.29],0.7988444209768497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,14169,257,1.10 [0.87-1.39],0.4136959667638153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,14583,261,1.02 [0.76-1.36],0.9002874120163795
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,14621,264,1.08 [0.85-1.38],0.5275856427298637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",16734,321,0.97 [0.88-1.06],0.4779680058852877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,14258,257,0.83 [0.61-1.13],0.2411907401147652
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,14339,253,1.20 [0.78-1.85],0.3981741979690453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,16913,324,0.95 [0.81-1.13],0.5754599316992542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,16991,324,1.13 [0.82-1.57],0.456551363338495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,16613,315,0.97 [0.78-1.21],0.8077052802995413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,16705,317,1.08 [0.96-1.22],0.1946291326342338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,14621,264,1.01 [0.86-1.20],0.8619179848072074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,14613,264,0.97 [0.77-1.24],0.8338966220148156
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,16991,324,1.17 [0.98-1.39],0.0860376947822424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,16846,321,1.19 [0.86-1.65],0.2873104331673133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,14270,256,0.97 [0.85-1.12],0.7069508119741175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,14270,256,1.26 [1.01-1.57],0.044359750388937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,14270,256,0.97 [0.79-1.20],0.799884448637916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,14130,252,1.12 [0.87-1.43],0.3736949911897562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,16916,324,0.94 [0.83-1.06],0.2842582266264451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,14621,264,0.82 [0.70-0.97],0.0207827538851794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,16705,317,0.88 [0.79-0.99],0.0340751941975207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,14571,263,0.96 [0.79-1.16],0.662039577820991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,14339,253,0.78 [0.62-0.99],0.0377351226621142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,14203,252,0.96 [0.82-1.11],0.5431509464997716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,16478,312,0.95 [0.79-1.14],0.558074053145412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,14621,264,1.08 [0.80-1.47],0.6087896075266435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,14270,256,0.94 [0.81-1.09],0.3954615287397757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,14571,263,0.87 [0.75-1.02],0.0914536570846965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,16740,314,1.20 [0.81-1.78],0.3605654444143631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,14190,256,0.99 [0.86-1.14],0.9258993504885008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,14571,263,0.94 [0.85-1.04],0.2359881126878793
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,14613,264,0.92 [0.73-1.15],0.4425575261618357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,16635,316,0.94 [0.79-1.12],0.5173966092076183
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,14621,264,1.12 [0.90-1.39],0.2936461450550566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,16827,314,0.82 [0.67-0.99],0.0417656624044379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,14258,257,0.60 [0.39-0.91],0.0160296907462807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,14190,256,0.94 [0.84-1.05],0.270608743641285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,14621,264,0.99 [0.91-1.08],0.7772791148251943
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,16771,321,0.99 [0.92-1.08],0.8728670061800546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,16606,316,1.01 [0.82-1.25],0.9062887514267802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,16705,317,0.95 [0.68-1.33],0.7673351456834316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,16744,318,1.16 [0.89-1.53],0.274934833614343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,16523,315,0.95 [0.66-1.37],0.783624380913817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,16705,317,1.01 [0.75-1.34],0.9715105729336848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,16647,320,0.96 [0.82-1.13],0.6495083752899544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,16991,324,1.29 [0.86-1.92],0.217664425087267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,16878,321,1.00 [0.84-1.18],0.9683607440901808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,16635,316,0.98 [0.77-1.23],0.8408954599882188
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,16705,317,0.95 [0.80-1.14],0.5999879220929738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,16617,316,1.23 [0.93-1.64],0.1438837899706566
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,14613,264,1.24 [0.89-1.72],0.1986112982177219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,16799,321,0.80 [0.56-1.15],0.2337891136261477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,16882,322,1.12 [0.84-1.48],0.4491642114369972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,16650,317,0.97 [0.79-1.19],0.7533586085099401
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,14339,253,0.95 [0.83-1.09],0.476222250391955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,14552,260,1.48 [1.14-1.93],0.003355499595513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,14258,257,0.93 [0.75-1.15],0.4972788701877406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,16705,317,1.03 [0.68-1.57],0.8811898624882631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,14631,263,0.88 [0.74-1.05],0.1579205388540968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,16478,312,1.06 [0.93-1.21],0.390960333184533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,14583,261,1.03 [0.77-1.36],0.8598395008659712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,14258,257,1.02 [0.85-1.22],0.8692362064281571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,16402,318,0.94 [0.83-1.06],0.3159938601381196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",14571,263,0.93 [0.83-1.05],0.2475823071288543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,14621,264,0.88 [0.67-1.14],0.3237816901036583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,14583,261,1.03 [0.80-1.33],0.7971487793268339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,14258,257,0.93 [0.79-1.08],0.337833800476238
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,14583,261,1.08 [0.82-1.41],0.5850695661867397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,16635,316,0.96 [0.87-1.07],0.5068940529504624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,16907,321,1.30 [0.94-1.80],0.1125334089005114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,16402,318,1.06 [0.81-1.39],0.6487106597972585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",14631,263,1.08 [0.92-1.26],0.354829653791799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",14270,256,0.96 [0.84-1.09],0.5202795029382706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,14169,257,1.04 [0.86-1.27],0.6792823760756693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,14269,257,0.85 [0.62-1.16],0.2982632298003875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,14190,256,0.92 [0.72-1.18],0.5279533286728066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,16938,322,1.31 [1.02-1.67],0.0325117657387655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,16744,318,0.94 [0.84-1.05],0.2601690505756631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,14583,261,0.93 [0.74-1.15],0.4905270852208867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,14169,257,0.78 [0.53-1.12],0.1789579430590324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,14613,264,1.01 [0.85-1.20],0.914094331039328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,16478,312,1.32 [0.99-1.76],0.059988393169796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,14270,256,1.35 [0.90-2.03],0.1416385848043196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,14204,254,1.21 [0.96-1.53],0.1150854484178032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,14631,263,1.00 [0.88-1.14],0.9862270245691936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,14571,263,1.15 [0.79-1.67],0.4599183123959803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,14373,259,0.96 [0.68-1.36],0.8187535837454796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,16857,322,0.94 [0.69-1.29],0.7188842063128205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,14613,264,1.00 [0.72-1.40],0.979170007439776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,16778,321,1.26 [0.90-1.75],0.1738466849952172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,16607,316,1.39 [1.02-1.88],0.0364510873122514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,14258,257,1.00 [0.80-1.25],0.9838664538559732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,16756,314,0.97 [0.88-1.07],0.5435711544434173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,16426,308,0.79 [0.61-1.04],0.0942497766138911
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,14571,263,1.15 [0.79-1.69],0.4573902448514148
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,16991,324,0.73 [0.40-1.35],0.3154148563905766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,16744,318,0.92 [0.76-1.12],0.4280718572684832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,14631,263,0.99 [0.84-1.16],0.8702342613055439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,14270,256,0.98 [0.89-1.09],0.720575661675184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",14621,264,0.99 [0.80-1.23],0.9507712091132848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",14507,261,0.97 [0.87-1.09],0.6375683463127478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,14169,257,1.03 [0.85-1.23],0.7846525618160552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,14270,256,0.99 [0.74-1.32],0.948038390598008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,16635,316,0.83 [0.70-0.99],0.0373323865384298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,14204,254,0.92 [0.80-1.06],0.2349723442518129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,16771,321,0.84 [0.72-0.99],0.0329354619146331
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,16954,324,0.97 [0.87-1.07],0.4887554671231642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,14613,264,0.99 [0.82-1.19],0.9073292448684634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,14169,257,0.87 [0.65-1.17],0.3600050392149682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,16485,311,1.05 [0.75-1.46],0.7871906115194548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,14613,264,0.97 [0.84-1.11],0.6615404549798194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,14190,256,0.94 [0.81-1.09],0.4226834142008284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELN,Elastin,14631,263,0.86 [0.61-1.22],0.4034414589444869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,16705,317,0.88 [0.72-1.07],0.205357037291779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,14169,257,0.97 [0.70-1.33],0.8294432743108252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,16485,311,1.05 [0.85-1.30],0.6412225043654249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,13495,252,1.06 [0.85-1.32],0.6251796073146809
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,16991,324,1.32 [0.75-2.32],0.3327737894460892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,16754,322,0.93 [0.82-1.05],0.2453476937913158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,16913,324,0.88 [0.75-1.03],0.1008394360687914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,14270,256,1.08 [0.88-1.32],0.4554532176789877
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,14583,261,0.91 [0.71-1.15],0.4223566355105214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,14169,257,0.69 [0.43-1.09],0.1082177448899048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,14169,257,0.58 [0.39-0.84],0.0047024691716699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,16991,324,0.80 [0.54-1.18],0.2560470846165254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,16845,315,1.04 [0.82-1.32],0.7323655448236011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,14270,256,0.92 [0.65-1.28],0.6032899651660097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,16206,301,1.10 [0.97-1.24],0.1385513813829169
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,14583,261,0.80 [0.63-1.02],0.0775465465798286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,16426,308,1.00 [0.79-1.27],0.9880883344554412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,16478,312,0.97 [0.61-1.53],0.8827055606846382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,16478,312,1.13 [0.78-1.64],0.5143452040855487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,14270,256,0.87 [0.70-1.09],0.2280191500579498
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,14204,254,1.00 [0.68-1.48],0.9942952262146704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,14258,257,0.92 [0.75-1.13],0.429373633623292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,16760,314,1.02 [0.92-1.13],0.6589090751349298
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,14583,261,0.85 [0.62-1.16],0.2981592280880192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,16827,314,1.22 [0.89-1.67],0.2260326608922697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,16402,318,0.93 [0.79-1.09],0.3620269203893036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,16191,301,1.24 [0.91-1.70],0.1760094980640928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,14339,253,1.17 [0.77-1.77],0.4555931650739221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,16991,324,1.40 [0.96-2.03],0.0798335686226246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,16606,316,1.09 [0.80-1.48],0.5709684953900782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,16478,312,0.94 [0.80-1.12],0.5127865135077097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,14373,259,1.12 [0.88-1.44],0.3590085723170046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,16744,318,1.10 [0.97-1.26],0.1405466827916806
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,14270,256,1.03 [0.87-1.22],0.7097744949693534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,16909,322,1.49 [1.09-2.04],0.0136561485605711
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,16846,321,1.11 [0.73-1.69],0.6314660157406358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,16738,314,1.17 [0.70-1.94],0.5545934216171707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,16846,321,1.08 [0.71-1.64],0.7127709901981109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,16705,317,0.98 [0.89-1.07],0.6157970557359835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,14258,257,1.07 [0.93-1.24],0.3565380263069109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,14130,252,1.09 [0.79-1.50],0.5935125785760813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,16606,316,0.96 [0.84-1.09],0.5269105139200142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,14373,259,0.97 [0.68-1.39],0.8798660221990415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,14204,254,0.94 [0.72-1.24],0.6724707201542819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,14583,261,1.22 [0.90-1.67],0.1996096436930651
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,14339,253,0.96 [0.87-1.07],0.4672915760951717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,16672,316,0.85 [0.57-1.25],0.4017001592515821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,14169,257,1.16 [0.89-1.51],0.2659272095921224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,16991,324,1.01 [0.75-1.37],0.9446038445816448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,16765,314,0.66 [0.49-0.89],0.0068817865345431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,14130,252,0.96 [0.77-1.20],0.7446862080597814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,14204,254,1.06 [0.85-1.31],0.6071799563848662
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,14621,264,0.96 [0.83-1.11],0.6077957139863261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,14130,252,0.89 [0.64-1.23],0.4777901504546281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,14204,254,1.00 [0.87-1.14],0.9788788360383142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,14373,259,0.96 [0.67-1.40],0.8499526971451397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,14169,257,0.82 [0.64-1.06],0.1240485499440774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,14169,257,0.94 [0.73-1.22],0.6517900435821032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,16913,324,1.04 [0.68-1.57],0.8659955782056806
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,14649,262,0.90 [0.60-1.35],0.615465287672879
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,14453,261,1.02 [0.69-1.51],0.9147660630435162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,16799,321,0.88 [0.73-1.05],0.1536417075266831
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,14658,262,1.23 [0.92-1.66],0.1680904779247154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,14583,262,1.08 [0.68-1.74],0.7355779312842718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,14658,262,1.00 [0.46-2.20],0.9912158356904388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,16820,315,1.01 [0.84-1.20],0.9559024991621335
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,16838,321,1.29 [0.89-1.87],0.1801990726160512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,16859,322,1.06 [0.77-1.46],0.7064339544771573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,16846,321,1.53 [0.89-2.62],0.1245477541407069
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",16765,314,1.08 [0.97-1.19],0.1527265105343592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",16771,321,1.05 [0.94-1.19],0.3854781185942917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",14631,263,1.30 [1.05-1.61],0.0164394805987765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",16991,324,1.09 [0.90-1.33],0.3784873731099724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,16852,323,1.00 [0.86-1.16],0.9839277921831328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,16448,312,1.15 [0.97-1.35],0.0998292961175191
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,16744,318,1.04 [0.88-1.24],0.6314446019016002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,16771,321,0.93 [0.81-1.06],0.283883423500288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,14571,263,0.95 [0.79-1.14],0.5608188721118774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,14613,264,1.03 [0.96-1.11],0.3574367162995032
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,14583,261,0.96 [0.61-1.49],0.8460806951473447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,14270,256,0.88 [0.72-1.07],0.2037236311334742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,14631,263,1.19 [0.79-1.80],0.4117066698379998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,16705,317,1.23 [0.92-1.66],0.1605493005326275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,16745,321,1.02 [0.74-1.42],0.892872784438482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,14571,263,1.04 [0.91-1.20],0.5350972050146346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,16991,324,0.88 [0.62-1.27],0.503084624751817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,14258,257,1.10 [0.94-1.29],0.2493567716708107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,16953,324,1.08 [0.81-1.43],0.6028210201611658
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,16954,324,0.78 [0.60-1.02],0.0705326502446088
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,14647,266,0.99 [0.68-1.45],0.950822349532926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,14258,257,1.03 [0.84-1.26],0.7804952878882432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",16771,321,1.10 [0.96-1.25],0.1639049312292386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,14631,263,1.12 [0.95-1.32],0.1760272508587398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,16744,318,0.85 [0.69-1.05],0.1243646149785043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,14613,264,1.19 [0.73-1.95],0.4855572899032901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,16799,321,0.88 [0.72-1.07],0.1996645292776437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,16748,320,0.99 [0.84-1.16],0.881313143245668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,16426,308,1.01 [0.85-1.21],0.9019458220726532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,16833,322,1.01 [0.83-1.24],0.914443626084426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,14621,262,1.04 [0.84-1.29],0.6902901099221058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,16734,318,1.05 [0.81-1.34],0.726683697785369
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,16771,321,1.07 [0.86-1.34],0.5275739117477951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,16868,322,1.14 [0.93-1.39],0.1985599950981082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,16485,311,1.01 [0.84-1.21],0.9390085949271844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,16799,321,0.94 [0.79-1.11],0.4547133082192783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,16744,318,1.08 [0.94-1.25],0.2892542510790436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,16426,308,1.00 [0.85-1.18],0.9520563597111896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",14169,257,0.93 [0.75-1.14],0.4580462938051024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",14169,257,1.12 [0.92-1.36],0.2521505248099422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,16426,308,0.93 [0.79-1.10],0.3983009390207717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,16426,308,0.77 [0.61-0.97],0.0289599220999527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,16846,321,0.90 [0.67-1.21],0.4942432111408681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,14318,259,1.06 [0.71-1.57],0.7734777060737008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",14613,264,0.99 [0.85-1.15],0.8714062780304872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,14204,254,1.12 [0.90-1.38],0.3107906987125568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,14204,254,1.00 [0.77-1.31],0.980553380222856
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,16845,315,1.06 [0.94-1.21],0.349663191439882
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,16744,318,1.00 [0.87-1.16],0.968566786561864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,14204,254,1.05 [0.82-1.36],0.6899422431056517
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,16907,321,1.04 [0.96-1.14],0.310807547382025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,16914,322,1.08 [0.90-1.28],0.4171555817037352
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,14204,254,0.94 [0.63-1.41],0.767218654293554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,16485,311,1.23 [0.91-1.66],0.1752614150446567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,14204,254,1.05 [0.78-1.40],0.7586850831359166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,14130,252,0.96 [0.81-1.13],0.6048408978353259
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,14108,252,0.70 [0.53-0.93],0.0121932213533903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,16846,321,0.85 [0.63-1.16],0.3078084094854132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,14647,266,0.91 [0.73-1.15],0.4500204509034823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,14621,264,0.95 [0.69-1.31],0.7577212529146555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,16846,321,1.50 [0.97-2.34],0.0706537479792123
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,14339,253,1.09 [0.87-1.38],0.4439283680983884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,14649,262,1.14 [0.95-1.37],0.151251943724815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,16402,318,0.93 [0.78-1.11],0.4310769268306692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",14190,256,1.01 [0.88-1.17],0.839591740759612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,14169,257,0.96 [0.74-1.23],0.7324417066617499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,16402,318,0.87 [0.76-1.00],0.056070240962884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,16789,314,0.98 [0.86-1.12],0.8110356296251473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,14613,264,1.01 [0.90-1.14],0.8774443630297796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,16816,321,0.92 [0.84-1.01],0.0791101333676892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,16635,316,0.81 [0.64-1.02],0.0698563584731687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,16635,316,0.96 [0.86-1.06],0.4065645722976938
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,16373,318,0.94 [0.75-1.17],0.5611349379044872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,14571,263,0.87 [0.71-1.06],0.1704831840871045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,16426,308,0.95 [0.87-1.05],0.3201605684158646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,16635,316,1.22 [0.86-1.73],0.2677977807464027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,16669,317,0.70 [0.43-1.13],0.1473899289916204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,16426,308,0.67 [0.47-0.96],0.0282695381908725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,16954,324,1.30 [0.98-1.73],0.0694540641950885
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,16846,321,1.10 [0.82-1.48],0.5226699764383084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,16402,318,0.97 [0.82-1.14],0.695836812956993
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,16426,308,1.08 [0.81-1.44],0.5908673441935384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,14658,262,1.08 [0.69-1.68],0.7302859565628366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,14621,264,1.00 [0.78-1.28],0.99065817561852
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,14583,261,0.95 [0.67-1.35],0.786825258254916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,14204,254,1.05 [0.94-1.17],0.3999018011060886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,16774,319,1.08 [0.77-1.52],0.6367560130802268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,16913,324,1.41 [1.01-1.96],0.0451662972572101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,16791,318,1.05 [1.00-1.10],0.0624605497718578
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,14108,252,1.03 [0.73-1.45],0.8708160934222027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,16402,318,1.08 [0.84-1.39],0.549702516094624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,14204,254,0.99 [0.75-1.32],0.9685208566352836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,16744,318,1.02 [0.91-1.15],0.7454497519493006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,16426,308,1.04 [0.93-1.16],0.4743695571076594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,14169,257,0.98 [0.82-1.17],0.8509333709011629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,14258,257,0.68 [0.49-0.96],0.0296472655170055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,16579,315,0.69 [0.47-1.04],0.0740848363150313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,14270,256,1.35 [1.09-1.67],0.0066440187553292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FST,Follistatin,16820,315,0.86 [0.70-1.06],0.1670125632581289
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,14270,256,1.17 [0.68-2.02],0.5670213371548882
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,16736,313,1.12 [0.82-1.54],0.4595547997986824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,14590,263,1.05 [0.91-1.21],0.4975285370894104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,16903,323,0.95 [0.84-1.06],0.3421856881704659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,14339,253,1.04 [0.85-1.27],0.6950754435793405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FURIN,Furin,16846,321,0.99 [0.72-1.34],0.9240406327522246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,16403,308,1.01 [0.77-1.31],0.9501388268646322
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",14338,259,1.20 [1.02-1.42],0.0272486659921797
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,16913,324,1.15 [0.94-1.43],0.1795679284537928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",16635,316,0.95 [0.80-1.13],0.5734121786016947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",16938,322,0.90 [0.79-1.04],0.14446672091626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,16485,311,1.01 [0.86-1.18],0.8853189328081074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,16764,321,0.94 [0.85-1.05],0.2639067092087241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,14258,257,0.90 [0.71-1.12],0.33921936067557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,14190,256,1.03 [0.79-1.34],0.8385245866263016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,14583,261,1.07 [0.84-1.36],0.6020001228799685
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,14373,259,1.05 [0.88-1.25],0.5755962579347398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,14190,256,0.80 [0.64-1.01],0.05707021834318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,14130,252,0.86 [0.54-1.37],0.524811379567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,14204,254,1.10 [0.88-1.39],0.4043140300961463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,14373,259,0.99 [0.78-1.26],0.9482479988173677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,14270,256,0.87 [0.68-1.10],0.2413420439112485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,14130,252,1.04 [0.87-1.24],0.6744749766102207
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,16845,315,1.03 [0.88-1.20],0.692917881370881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,16705,317,1.13 [0.79-1.62],0.5102875753581539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,16938,322,1.26 [0.87-1.81],0.2214977782021819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,16485,311,0.96 [0.76-1.21],0.7158286198951256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,14631,263,1.09 [0.73-1.65],0.671055488354937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,16705,317,1.67 [1.03-2.71],0.0388457493242587
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,14169,257,0.97 [0.69-1.38],0.8840909293237887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,14015,249,0.72 [0.51-1.03],0.0684778795823375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,14613,264,0.96 [0.61-1.52],0.8757048681366983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,14373,259,1.05 [0.84-1.31],0.6880803202418975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,16901,323,1.07 [0.72-1.59],0.7379524404272039
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,14169,257,0.95 [0.72-1.26],0.7292390712894912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,14621,264,1.08 [1.01-1.17],0.0366852355726063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,14130,252,0.99 [0.62-1.56],0.9582519074666332
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",14270,256,0.95 [0.80-1.11],0.5060044298424549
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,14258,257,0.92 [0.74-1.15],0.484479934617086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,14594,263,1.11 [0.93-1.34],0.2477610797907262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,16485,311,1.02 [0.86-1.21],0.8005204840360413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,16402,318,1.09 [0.90-1.33],0.3738901966300386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,14169,257,0.95 [0.72-1.25],0.7104053631811087
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,14658,262,0.92 [0.58-1.45],0.707136722359923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,14621,264,0.97 [0.87-1.08],0.5981111725677795
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,16426,308,1.05 [0.97-1.14],0.1978160083586118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,14000,245,0.95 [0.73-1.23],0.7001916405442107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,14169,257,0.86 [0.65-1.15],0.3182797993203915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",16705,317,1.09 [0.82-1.46],0.5573836283145737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,16991,324,1.47 [1.21-1.78],0.0001205871440835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,16771,321,1.01 [0.76-1.33],0.9542995613142043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,16402,318,1.21 [0.94-1.56],0.1461513344971991
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,14631,263,1.12 [0.90-1.38],0.3083791084494841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,16394,308,0.97 [0.78-1.20],0.7623121557166102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,16426,308,1.08 [0.92-1.27],0.3338114023331709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,16426,308,1.04 [0.96-1.12],0.3886658935016464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,16907,321,1.49 [1.07-2.07],0.0188974119307584
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,16705,317,0.94 [0.58-1.50],0.789137430638157
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,16594,316,1.19 [0.84-1.69],0.3312354562679039
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,14167,253,0.96 [0.79-1.18],0.7229515639996045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,16402,318,1.03 [0.88-1.19],0.7401111791134227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,14631,263,0.92 [0.78-1.09],0.3514709246482423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,14598,263,0.77 [0.59-1.00],0.0480711769140342
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,16543,314,0.99 [0.74-1.34],0.9731636869085803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,16778,321,1.15 [0.94-1.39],0.1664896668523858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,16635,316,1.11 [0.72-1.70],0.6284530054157609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,16745,321,1.02 [0.97-1.08],0.4094333247550721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,16426,308,1.02 [0.96-1.08],0.5534650837922663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,14339,253,0.97 [0.63-1.50],0.8861483245211405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,16402,318,1.07 [0.90-1.27],0.4449163072578015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,16771,321,1.04 [0.93-1.17],0.5059374540229074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,14613,264,1.22 [0.92-1.62],0.1602883752920496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,14613,264,1.00 [0.86-1.18],0.9663222936670236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,14339,253,0.86 [0.57-1.29],0.4536150799253151
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,14130,252,1.21 [0.99-1.49],0.0682927236377568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,14270,256,1.17 [0.97-1.43],0.1058560750737898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,14621,264,1.35 [0.94-1.93],0.1087314998176258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,14571,263,0.93 [0.83-1.05],0.2314639341808153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,14204,254,1.14 [0.90-1.44],0.2805545732460753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,14204,254,0.99 [0.87-1.12],0.8695139967640992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,14130,252,0.84 [0.67-1.04],0.1102923842206465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,16089,307,1.29 [0.90-1.84],0.1675224195113356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,14315,253,1.26 [0.91-1.74],0.1622663913416935
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,16635,316,0.89 [0.69-1.13],0.3305997483015533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,14204,254,1.14 [0.79-1.66],0.4884754783476324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,16478,312,0.98 [0.82-1.16],0.8035849019463743
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,16764,314,0.73 [0.55-0.98],0.0371420512949118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,14190,256,1.07 [0.78-1.46],0.6692764383765791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,16652,320,0.81 [0.68-0.97],0.0201277701663035
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",14339,253,0.92 [0.80-1.06],0.2589427529377051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,16402,318,0.92 [0.73-1.17],0.4901618899340921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,14583,261,0.91 [0.73-1.14],0.431465517022351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,14284,261,1.09 [0.81-1.48],0.560518707942901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,14631,263,0.90 [0.76-1.07],0.2299953929568621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,16954,324,0.80 [0.66-0.98],0.0273358801288562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,14339,253,0.89 [0.74-1.07],0.2288148748233623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,14613,264,1.10 [0.96-1.25],0.1727064634463813
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,16426,308,0.94 [0.80-1.10],0.4113949524483863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,14258,257,0.92 [0.71-1.19],0.537699232169522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,16799,321,1.07 [0.89-1.28],0.4677540055998568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,14270,256,0.83 [0.56-1.24],0.3681710101850172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,14339,253,0.93 [0.66-1.30],0.6668973141010741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,14613,264,1.04 [0.90-1.21],0.5787244143336554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,16913,324,1.54 [1.05-2.27],0.0280874387410681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,16744,318,1.00 [0.91-1.10],0.980559076660094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,14571,263,1.01 [0.78-1.29],0.9587017988112684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",14647,266,1.22 [0.93-1.59],0.1583958685530473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,16736,320,0.97 [0.72-1.32],0.8590651968774431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,14169,257,0.99 [0.83-1.18],0.9197228574770484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,16283,308,1.04 [0.92-1.17],0.5651080597664022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,14339,253,1.00 [0.71-1.40],0.9922515120333428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,16764,321,0.92 [0.82-1.03],0.1448660942447227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,16705,317,1.00 [0.93-1.07],0.8936870980821002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,16938,322,1.01 [0.72-1.41],0.9517553828659736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,16635,316,0.93 [0.78-1.11],0.4173668751586371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,14583,261,1.28 [1.03-1.59],0.0242525434940734
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,14571,263,1.01 [0.77-1.31],0.9682009550435662
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,14649,262,1.02 [0.79-1.31],0.8829177418230199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,14571,263,1.00 [0.85-1.17],0.9588276940913876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,16402,318,0.80 [0.55-1.17],0.2519384511811423
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,16322,316,0.78 [0.55-1.10],0.150129643722944
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,14190,256,1.01 [0.82-1.25],0.9029837312108688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,14613,264,1.05 [0.75-1.46],0.7939687587459742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,14571,263,0.95 [0.78-1.15],0.5990619010653113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,16478,312,1.00 [0.86-1.17],0.9924723887607698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,14583,261,1.15 [0.94-1.41],0.1789607029488782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,16771,321,0.97 [0.90-1.05],0.5055755685277465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,14631,263,0.95 [0.78-1.14],0.5653127505456058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",14613,264,0.82 [0.61-1.09],0.1673152847516967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",14190,256,0.94 [0.74-1.19],0.5887145619525787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,16478,312,0.89 [0.71-1.11],0.2990251168441472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,16721,320,1.56 [1.03-2.34],0.0348418530722045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,14270,256,1.03 [0.82-1.28],0.8227006731258922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",16705,317,1.03 [0.86-1.22],0.762560368610667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,14053,251,0.95 [0.81-1.10],0.4767660858327075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,16426,308,1.03 [0.92-1.16],0.5908227431976014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,14597,261,0.74 [0.41-1.32],0.3004494359905167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",14565,260,1.02 [0.59-1.76],0.9373853977432244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,16741,320,1.09 [0.97-1.23],0.1395154443541614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,16426,308,1.09 [0.96-1.24],0.2026782841049174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,14169,257,1.01 [0.86-1.19],0.8795069442939916
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,16304,316,1.03 [0.90-1.19],0.6657266766802897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,14621,264,0.98 [0.94-1.03],0.5405979961741074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,14373,259,1.04 [0.88-1.23],0.6167301459925919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,14258,257,0.96 [0.83-1.12],0.5933806204851895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,16708,321,1.24 [0.94-1.64],0.1265493962770858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,14373,259,1.01 [0.87-1.17],0.8825259410400644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,14169,257,0.98 [0.71-1.35],0.9119229659970042
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,16887,323,1.07 [0.92-1.25],0.3966494531117616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",16478,312,0.99 [0.88-1.10],0.8232831448576615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,16954,324,1.28 [0.97-1.70],0.0832509813226897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,16744,318,0.98 [0.84-1.15],0.8157450366355232
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,16478,312,1.03 [0.91-1.17],0.6107303826908274
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,14130,252,0.94 [0.72-1.21],0.6221345145408133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",14169,257,1.00 [0.85-1.19],0.9801744474250637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",16879,321,0.90 [0.78-1.03],0.1250850771367585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,16938,322,1.06 [0.98-1.14],0.1719200078281427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",16799,321,0.93 [0.81-1.05],0.2496157551366098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,16910,322,1.27 [1.10-1.48],0.0015756757299507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,16799,321,1.04 [0.79-1.37],0.7780355855535348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,16879,321,0.96 [0.84-1.10],0.598118105128051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,16938,322,0.87 [0.74-1.03],0.1100667847136176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,14631,263,1.02 [0.91-1.14],0.6991644615866744
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,14169,257,0.90 [0.71-1.16],0.4278332386194898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,16954,324,0.90 [0.75-1.07],0.2252362418315449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,14204,254,1.02 [0.83-1.25],0.8419815829011823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,14190,256,0.89 [0.72-1.09],0.2487409289665439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,14571,263,0.94 [0.72-1.24],0.6752077252428317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,16904,322,0.98 [0.88-1.09],0.7011710684709227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,14621,264,0.97 [0.80-1.17],0.7265809225246236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,16478,312,1.05 [0.87-1.27],0.5947309790041728
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,14339,253,1.67 [1.08-2.61],0.0224267225279286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,14621,264,1.01 [0.77-1.32],0.9583558245446376
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,14631,263,1.17 [0.76-1.82],0.4752383137600638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,16744,318,0.95 [0.84-1.08],0.4150358111798057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,16954,324,1.14 [0.85-1.51],0.3874149645780486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,14511,260,0.81 [0.54-1.20],0.2891264084997866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,16426,308,0.94 [0.82-1.07],0.3531930487196416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,14621,264,1.05 [0.90-1.22],0.5680047354935372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,14204,254,1.29 [1.12-1.49],0.0004883084913908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,14169,257,0.88 [0.60-1.29],0.5089712398208794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,14585,264,1.18 [0.93-1.50],0.169106594955962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,14613,264,1.15 [0.89-1.49],0.2800843003579273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,16478,312,0.93 [0.64-1.34],0.6894288839493445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",14613,264,0.99 [0.69-1.41],0.9474164552448132
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",16697,316,1.19 [0.91-1.56],0.1968604072730721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",16744,318,1.13 [0.81-1.58],0.4563996374131561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,16938,322,0.81 [0.64-1.02],0.0687847690176403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,14315,253,0.99 [0.81-1.23],0.9589647723106246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",14270,256,0.91 [0.70-1.18],0.4725424138963141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",14169,257,1.04 [0.80-1.36],0.7594241740322624
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,14099,251,1.27 [1.03-1.55],0.0228800070012357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,16600,321,0.91 [0.74-1.12],0.3577895604694635
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,16402,318,0.91 [0.72-1.15],0.4391557941508939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,14258,257,0.94 [0.78-1.13],0.4910052834767906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,16555,316,1.00 [0.81-1.24],0.9906842467955822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,16434,312,0.95 [0.83-1.08],0.4175201281109048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,14613,264,0.88 [0.68-1.13],0.3188560771809869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,16954,324,0.95 [0.84-1.09],0.4760987537236306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,16426,308,0.85 [0.64-1.11],0.2305676316602092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,14454,265,0.96 [0.85-1.09],0.5655455095217883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,14337,259,0.96 [0.84-1.10],0.5588780765548883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,14270,256,0.95 [0.65-1.38],0.7924713798893221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,14583,262,1.26 [0.87-1.83],0.2257047053438669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,14270,256,0.92 [0.80-1.06],0.245784420650581
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,16705,317,1.16 [0.89-1.52],0.2615153384870984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,16938,322,1.23 [0.96-1.57],0.1038679749261186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,14204,254,1.29 [0.93-1.78],0.1317605364818402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,14270,256,0.97 [0.85-1.11],0.6659856396376282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,16744,318,1.01 [0.79-1.29],0.951978867349131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,14621,264,0.98 [0.81-1.18],0.8198609917673286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,14169,257,0.96 [0.75-1.23],0.7472655461620404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,14270,256,0.86 [0.66-1.11],0.2448440643661608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,16320,317,1.01 [0.86-1.17],0.9289656841848964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,16827,314,0.93 [0.80-1.07],0.3105385246381313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,14583,261,1.03 [0.72-1.47],0.8704078956076582
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,16531,319,0.94 [0.82-1.08],0.398429486262518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,16938,322,1.41 [1.11-1.79],0.004480213836136
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,16690,317,1.12 [0.77-1.61],0.5549674487456109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,14190,256,1.06 [0.92-1.24],0.4137499169318255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,14190,256,0.88 [0.66-1.18],0.3975051144075886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",16846,321,1.01 [0.86-1.19],0.9026992240541866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,16721,318,0.95 [0.61-1.47],0.8135063450503516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,16991,324,1.27 [0.83-1.92],0.2716842250379443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,16485,311,1.02 [0.89-1.16],0.8083197847121545
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,16742,320,1.14 [0.80-1.61],0.4636734298330476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,16991,324,1.13 [0.83-1.52],0.4354598189483311
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,16991,324,0.98 [0.67-1.44],0.929886380771212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,16744,318,0.77 [0.64-0.93],0.0067339822137959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,16771,321,1.06 [0.85-1.31],0.6009779119207521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,16705,317,0.97 [0.58-1.64],0.9154223336390828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,14373,259,1.07 [0.83-1.39],0.5825413605547552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,16402,318,1.04 [0.85-1.28],0.6769137323949725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",14270,256,1.04 [0.86-1.27],0.6693401457612183
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,16954,324,1.18 [0.38-3.65],0.7737769456908312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,16938,322,0.85 [0.69-1.05],0.1293478726496968
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,14204,261,1.32 [0.98-1.79],0.0656065950511366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,14373,259,1.05 [0.83-1.31],0.7005155468973704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,14373,259,0.93 [0.67-1.28],0.6436515623893939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,14571,263,0.87 [0.54-1.40],0.5591707059224498
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,16485,311,1.00 [0.91-1.10],0.98981944761562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,16845,315,1.12 [0.70-1.78],0.6445097373598785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,16635,316,0.92 [0.76-1.12],0.4052324005518906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,16402,318,0.82 [0.65-1.03],0.0810970893085323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,14190,256,1.01 [0.83-1.23],0.9078936709427792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,16744,318,1.29 [1.00-1.66],0.0513786227372634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,14169,257,0.83 [0.57-1.21],0.3234391783983089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,14258,257,0.96 [0.73-1.28],0.7958953999796696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,14613,264,0.86 [0.71-1.05],0.1362298842335014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,14190,256,0.94 [0.72-1.22],0.6250938838426519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,14647,266,1.10 [0.71-1.71],0.6680020631782674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,16705,317,1.04 [0.66-1.66],0.85239219194224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,14169,257,1.07 [0.83-1.39],0.5981541965218855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,16799,321,1.40 [0.92-2.14],0.115241816014073
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,16969,324,0.91 [0.84-0.99],0.0237968169644654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,16968,323,1.03 [0.87-1.21],0.7395554872214545
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,16877,322,1.05 [0.77-1.42],0.76824237023792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,16598,318,1.20 [0.97-1.48],0.088068843063381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,16734,320,1.26 [0.93-1.71],0.1317301660896121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,16991,324,1.58 [1.20-2.08],0.0010048198368482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,16771,321,1.19 [0.89-1.59],0.230534283208696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,14204,254,1.06 [0.91-1.23],0.4708563675697893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,14169,257,1.03 [0.83-1.27],0.7966923648593802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,14628,262,0.87 [0.52-1.46],0.6056629118455095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,14130,252,0.92 [0.80-1.07],0.3035494617847241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,14270,256,0.74 [0.53-1.04],0.0853831796502444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,16705,317,1.45 [1.09-1.91],0.0099377066883309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,16771,321,1.00 [0.72-1.38],0.9832936076132388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,14631,263,1.07 [0.93-1.23],0.3339444470751691
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,16744,318,1.02 [0.91-1.14],0.7432545182102634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,16426,308,1.08 [0.97-1.21],0.1398075144806803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,16485,311,1.05 [0.93-1.18],0.4525490863525432
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,16485,311,1.01 [0.85-1.20],0.8926958756783263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,16845,315,1.23 [0.88-1.71],0.2196372835303781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,16485,311,0.99 [0.84-1.17],0.8897721410494237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,16705,317,1.08 [0.95-1.22],0.2526388841146477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,16954,324,1.14 [0.95-1.36],0.1553699491139522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,16485,311,1.10 [0.84-1.43],0.4956523161155742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,14204,254,0.79 [0.58-1.10],0.160362565644049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,16485,311,1.10 [0.92-1.31],0.2802648621349454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,16590,314,1.24 [0.80-1.91],0.3426971652512426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,14190,256,0.90 [0.59-1.35],0.5985831040026101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,16744,318,1.01 [0.75-1.37],0.9270194437477824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,16485,311,0.94 [0.70-1.25],0.6560785867979458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,16954,324,0.79 [0.62-1.01],0.0639388571180509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,16464,311,0.96 [0.76-1.23],0.7693752930698954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,16485,311,1.01 [0.88-1.15],0.9174327838756372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,16485,311,0.88 [0.64-1.21],0.4192470519021495
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,16485,311,0.97 [0.84-1.12],0.6861907421713438
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,16799,321,1.14 [0.91-1.42],0.2532338635027895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,16540,314,1.07 [0.89-1.30],0.4554145977429523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,16717,313,0.89 [0.71-1.12],0.3237575616349765
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,16877,322,1.14 [0.83-1.56],0.4062840255369573
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,16954,324,1.61 [1.20-2.16],0.0015356918359066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,16528,313,0.97 [0.91-1.03],0.3478631201215065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,16342,311,1.10 [0.96-1.26],0.160515218293895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,16485,311,1.02 [0.86-1.20],0.8417102410870593
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,16415,310,1.03 [0.86-1.23],0.7554544062872002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,16778,321,1.34 [0.88-2.03],0.17631720649347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,16747,314,1.61 [0.97-2.67],0.0654579017093972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,16799,321,1.16 [0.94-1.43],0.1787902925714701
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,16953,324,1.09 [0.88-1.36],0.4197643521721403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,16485,311,1.01 [0.77-1.33],0.9200884910812508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,16756,314,1.12 [0.93-1.34],0.226548010957913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,16485,311,1.03 [0.75-1.42],0.8480681659084673
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,16485,311,0.93 [0.75-1.15],0.5159225303120591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,16485,311,0.90 [0.70-1.16],0.4062753267280623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,14204,254,0.93 [0.69-1.25],0.6315857625022483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,14204,254,1.04 [0.85-1.28],0.6744348517439913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,14583,261,1.01 [0.85-1.20],0.903399081469954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,16485,311,1.15 [0.95-1.40],0.151118969157435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,16485,311,0.99 [0.81-1.21],0.9309183367887736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,14078,252,1.15 [0.81-1.64],0.4383615313532223
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,16662,319,1.11 [0.87-1.42],0.4067631565176766
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,16485,311,1.08 [0.84-1.40],0.5295708252132456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,14583,261,1.12 [0.83-1.52],0.4518268277938781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,14130,252,1.05 [0.86-1.29],0.6050787576430384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,14204,254,1.04 [0.84-1.28],0.7450907561041221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,14142,253,1.08 [0.78-1.49],0.6553844605709213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,16744,318,1.07 [0.85-1.35],0.5487598813855824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,16485,311,0.94 [0.72-1.21],0.6094527130701791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,16378,317,1.08 [0.82-1.43],0.5652138185067364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,14204,254,0.92 [0.73-1.15],0.4441636385529791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,14141,253,0.92 [0.76-1.12],0.4092456958417618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,16485,311,1.13 [0.82-1.54],0.4496872184750863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,16485,311,0.94 [0.85-1.04],0.229404652747703
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,16744,318,1.11 [0.84-1.45],0.4690977073078365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,16485,311,1.01 [0.95-1.09],0.6919668468709226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,16744,318,0.90 [0.75-1.08],0.2575098680490326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,16705,317,0.97 [0.85-1.11],0.6818906282834092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,16720,320,0.85 [0.64-1.14],0.2875142266721135
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,16771,321,1.18 [0.67-2.09],0.5671968778656273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,16744,318,0.95 [0.81-1.11],0.4931185674086096
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,16799,321,1.01 [0.84-1.22],0.8985639243675074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,14373,259,0.99 [0.80-1.22],0.9142963270995064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,16381,318,0.97 [0.81-1.15],0.7182859715289276
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,14583,261,1.08 [0.83-1.40],0.5752061091484235
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,16635,316,0.94 [0.80-1.11],0.4867169766090992
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,14621,264,0.89 [0.72-1.11],0.300354794411654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,14190,256,0.89 [0.59-1.34],0.5684433796961967
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,16373,318,0.92 [0.74-1.14],0.4416682430941607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,14339,253,1.09 [0.87-1.36],0.4601341725757623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,16799,321,1.11 [0.87-1.43],0.3975700376380572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,16705,317,0.99 [0.82-1.20],0.931173255617736
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",14270,256,0.91 [0.73-1.13],0.3731247252996416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",14613,264,0.96 [0.72-1.28],0.7991425198431796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",16705,317,1.01 [0.91-1.12],0.9042471785801742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,14621,264,0.98 [0.85-1.12],0.7408027878672667
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,14583,261,1.00 [0.78-1.27],0.9813957441381828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,14571,263,1.07 [0.95-1.21],0.2354285493518114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,14204,254,1.31 [0.64-2.68],0.4570156970671529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,16607,316,0.96 [0.86-1.08],0.5257633161774041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,16705,317,1.03 [0.86-1.24],0.7489413459351026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",16478,312,0.96 [0.86-1.08],0.5368440104067196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,16485,311,1.01 [0.87-1.17],0.8989724027887892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,16744,318,0.97 [0.89-1.07],0.5886418114545726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,16179,311,0.88 [0.67-1.14],0.3347085072148416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,16744,318,0.89 [0.68-1.15],0.3669087167363937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,14647,266,1.03 [0.78-1.35],0.8564330178961377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,14456,263,0.94 [0.83-1.06],0.2829254311222966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,16744,318,0.67 [0.50-0.90],0.0073076216582614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,14339,253,0.83 [0.59-1.18],0.3001140543261091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,16799,321,1.45 [0.97-2.15],0.069265724581514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,16744,318,0.93 [0.76-1.14],0.4865994597586704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,14204,254,1.24 [0.93-1.65],0.1475696102133528
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,16799,321,0.90 [0.66-1.23],0.5122152770871218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,16938,322,0.64 [0.35-1.15],0.1368612177990844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,14373,259,1.14 [0.93-1.40],0.1939699058125526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,16806,322,0.80 [0.49-1.29],0.3565776255294319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,16426,308,0.95 [0.74-1.22],0.6699423186216522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,16478,312,0.95 [0.87-1.04],0.2572041590903434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,16700,319,0.95 [0.66-1.36],0.7835868542371642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,16846,321,0.80 [0.61-1.06],0.1158560684508488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,16485,311,1.06 [0.76-1.47],0.7281036133000918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,16938,322,1.06 [0.86-1.31],0.5625344310106637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,14647,266,1.35 [1.00-1.81],0.0470760777903757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,14658,262,0.91 [0.48-1.72],0.7616217901104385
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,16877,322,1.20 [0.92-1.57],0.1680253732716251
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,14658,262,0.86 [0.53-1.40],0.545159043686682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,14583,261,0.96 [0.74-1.26],0.7751036083896559
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,16744,318,0.98 [0.83-1.15],0.7986164355963077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,14169,257,0.98 [0.82-1.18],0.8483832635583806
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",14270,256,1.00 [0.84-1.20],0.997694247718078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",14190,256,0.92 [0.69-1.22],0.5597354536920327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",16402,318,1.09 [0.90-1.31],0.3893969113650187
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,14130,252,1.14 [0.90-1.45],0.2656767221509964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,16913,324,1.31 [0.92-1.86],0.1386509859546555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,14339,253,0.91 [0.71-1.17],0.4569215869780182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,16485,311,1.07 [0.91-1.26],0.4150139795679142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,14130,252,0.93 [0.75-1.16],0.5420502824259855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,14571,263,0.94 [0.82-1.08],0.3765072714424871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,16485,311,0.97 [0.78-1.20],0.7596148650882615
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,16705,317,1.03 [0.83-1.28],0.7970472739669937
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,14571,263,0.99 [0.88-1.10],0.8049434008289689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,14190,256,1.11 [0.91-1.36],0.2945595444943002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,14258,257,0.97 [0.83-1.14],0.7501986344791922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,16402,318,1.07 [0.89-1.30],0.4615373279542365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,14356,260,1.23 [0.96-1.58],0.1003278703892426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,14204,254,1.04 [0.91-1.19],0.5501200218153643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,16846,321,1.50 [1.01-2.23],0.0461562779741355
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,16402,318,0.92 [0.70-1.21],0.5594029186666165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,14130,252,0.98 [0.83-1.17],0.8657631392895304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,14270,256,0.95 [0.78-1.16],0.6289305033912876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,14621,264,0.89 [0.61-1.31],0.5653261275044434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,14373,259,0.97 [0.82-1.15],0.7569822838885755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,14373,259,0.80 [0.52-1.25],0.3310827013005796
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,14583,261,1.10 [0.91-1.35],0.3260954688436118
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,14169,257,0.96 [0.67-1.39],0.8451780185695541
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,14190,256,0.97 [0.83-1.15],0.7366432074437412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,14169,257,1.00 [0.91-1.11],0.950734992115854
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,16705,317,0.94 [0.84-1.06],0.3152979149811677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,14583,261,1.20 [1.05-1.36],0.0063363057856927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,16426,308,1.17 [1.04-1.33],0.0111236699376288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,14571,263,1.06 [0.99-1.13],0.0999742969560702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,16426,308,0.98 [0.90-1.06],0.587645392310116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,14130,252,0.88 [0.74-1.04],0.1295286127757258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,14190,256,0.95 [0.76-1.19],0.6639505067940746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,16402,318,1.14 [0.90-1.45],0.2730229039543483
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,16846,321,0.84 [0.60-1.17],0.3108542733959542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,16771,321,0.83 [0.64-1.08],0.1713017073912986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,16402,318,1.01 [0.89-1.16],0.8371597768775292
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,14190,256,0.82 [0.60-1.12],0.2098848418079678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,14613,264,1.21 [0.96-1.51],0.1024897979964234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,16622,318,1.02 [0.95-1.10],0.5731237906289536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,16794,321,0.94 [0.73-1.20],0.592063677826927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,16687,320,1.08 [0.80-1.45],0.629175560136642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,16426,308,1.02 [0.95-1.10],0.6054199972856067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,16421,315,1.01 [0.81-1.26],0.915657131864182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,16938,322,0.86 [0.70-1.06],0.1594112199825847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,14558,259,1.13 [0.90-1.42],0.2887588229769579
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,14647,266,1.19 [1.07-1.33],0.0011439068174509
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,16938,322,1.08 [0.93-1.26],0.3043138865887448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,16817,321,0.97 [0.70-1.33],0.8411998877925115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,13979,248,1.11 [0.80-1.53],0.5307556954408912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,16244,312,1.15 [0.88-1.51],0.3112413488627219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,14345,260,0.99 [0.60-1.61],0.9529207560345874
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,16954,324,1.30 [1.01-1.66],0.0379064794492282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,14190,256,1.04 [0.85-1.27],0.6979386739778416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,16954,324,1.46 [1.19-1.80],0.0003169195564127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,14204,254,1.17 [0.92-1.49],0.2107588347496093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,14621,264,1.17 [0.92-1.50],0.2061677538341979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",15872,308,1.04 [0.74-1.47],0.8248800365951079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",14169,257,1.19 [0.89-1.58],0.2422699565799746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",16705,317,1.12 [0.99-1.26],0.0719441133043642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",16709,318,1.12 [0.97-1.29],0.1190494521070315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",16402,318,1.08 [0.89-1.30],0.4482772792967764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",14169,257,0.77 [0.53-1.11],0.1642316182108871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",14190,256,1.12 [0.99-1.27],0.0818354516745982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,16751,321,0.83 [0.70-1.00],0.048605403747817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,16954,324,1.05 [0.84-1.31],0.6752828341951682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,16846,321,1.09 [0.78-1.53],0.6160053062152362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,14631,263,0.97 [0.85-1.11],0.6754204370281031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,14549,261,1.02 [0.80-1.30],0.8596347416485074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,16771,321,0.91 [0.78-1.06],0.2328659570292025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,16705,317,1.05 [0.81-1.35],0.7223550242586455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,16765,314,1.03 [0.79-1.35],0.8091698255570059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,16635,316,1.05 [0.95-1.15],0.3356460581695319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,14169,257,0.96 [0.75-1.22],0.7162257049419283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,16845,315,0.88 [0.65-1.18],0.3815788194689808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,14270,256,1.05 [0.71-1.57],0.802243791321489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,14233,258,1.13 [0.74-1.73],0.5670796149399406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,16269,311,1.70 [1.03-2.81],0.0395073847778583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,16928,323,1.08 [0.89-1.30],0.4412445429162503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,14583,261,0.95 [0.70-1.29],0.7415030178512898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,16485,311,0.94 [0.76-1.16],0.5709103477296907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,14583,261,0.94 [0.78-1.15],0.5718544167004966
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,16954,324,0.96 [0.84-1.09],0.5320325648098487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,16705,317,1.04 [0.96-1.12],0.3590414652464504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,14204,254,0.97 [0.84-1.12],0.6992725840541419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,16606,316,1.21 [0.92-1.59],0.1681915954226465
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,16877,322,0.97 [0.82-1.14],0.7066460629010272
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,16913,324,0.85 [0.73-1.00],0.0485312418300925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,14649,262,1.09 [0.63-1.88],0.7570209638200291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,14613,264,1.05 [0.88-1.27],0.5756707641762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,16328,313,0.92 [0.71-1.19],0.5253978217794655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,14647,266,0.99 [0.77-1.27],0.928796298374562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,16834,322,0.95 [0.78-1.16],0.6201234126816504
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,14613,264,1.01 [0.89-1.14],0.8890811168820844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,14631,263,1.01 [0.84-1.21],0.9320739175374462
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,16907,321,0.91 [0.75-1.11],0.3618005551204326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,13868,240,1.16 [0.97-1.39],0.0940028042685957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,14190,256,0.87 [0.72-1.05],0.1539806484716163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,14613,264,1.24 [0.95-1.62],0.1180613770905372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEP,Leptin,16771,321,0.93 [0.80-1.07],0.3057339944741045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,16771,321,0.84 [0.61-1.16],0.3017789879419704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,14613,264,0.99 [0.79-1.24],0.9250319869353648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,16771,321,1.05 [0.79-1.39],0.7483803862870009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,16837,322,0.85 [0.61-1.18],0.3399685065318882
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,14658,262,1.30 [0.91-1.87],0.1444125005619629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,16765,314,1.34 [1.14-1.58],0.0004912719896788
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,16747,317,1.11 [0.88-1.39],0.3864443494638381
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,16913,324,0.96 [0.82-1.14],0.6637177104948384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,16782,315,1.12 [0.81-1.54],0.5074399343749284
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,16845,315,1.27 [0.97-1.68],0.0851040151767421
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,16426,308,0.95 [0.84-1.07],0.4067168761931227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,16794,314,0.85 [0.72-1.00],0.0494823137676476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,16402,318,1.12 [0.94-1.34],0.1982340642574396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,16744,318,1.03 [0.68-1.56],0.8953167793044555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,16799,321,1.02 [0.77-1.34],0.9035215670833616
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,14647,266,1.03 [0.94-1.12],0.5687587537104026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,14169,257,0.97 [0.77-1.24],0.8266301901197664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,16745,321,1.14 [0.84-1.55],0.4052311393735414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,14631,263,0.89 [0.76-1.04],0.1294756701625518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,16991,324,1.07 [0.75-1.54],0.6953484874086963
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,16930,323,1.01 [0.76-1.34],0.9514357853772196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,16485,311,1.13 [0.90-1.41],0.2936669509573336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,16991,324,0.97 [0.85-1.12],0.6953047749731472
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,14270,256,1.01 [0.83-1.22],0.919570280460052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,14546,263,0.92 [0.76-1.12],0.4229887327727913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,14621,264,1.14 [0.75-1.73],0.5274614457841686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,14613,264,1.07 [0.76-1.49],0.7013536269574951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,14190,256,0.92 [0.74-1.13],0.4287518108357263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",14270,256,0.90 [0.78-1.04],0.1516677662530924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),14324,259,1.01 [0.94-1.08],0.816774901956445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,16705,317,0.97 [0.75-1.24],0.7798829240125752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,16771,321,0.78 [0.64-0.95],0.0146243185156366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,16201,308,1.29 [1.09-1.52],0.0030271516624677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,14169,257,1.08 [0.89-1.30],0.4300270840676817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,14169,257,1.01 [0.84-1.21],0.9129538030797316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,14258,257,1.08 [0.83-1.40],0.5831798897078493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,14658,262,1.65 [1.06-2.56],0.0259070732882878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,16879,321,0.98 [0.74-1.30],0.8985646250742823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,14152,254,0.94 [0.60-1.47],0.7927851700640303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,16705,317,1.04 [0.72-1.52],0.8167553356706038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,16771,321,1.08 [0.83-1.41],0.5641423434278907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,14258,257,1.07 [0.78-1.47],0.680023774670445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,14258,257,0.93 [0.80-1.09],0.3968882944574828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,16913,324,1.11 [0.95-1.30],0.1806643715854179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,16705,317,1.11 [0.87-1.43],0.3998171254419841
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,14571,263,1.14 [0.87-1.49],0.3514742406619244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,14258,257,1.14 [0.91-1.44],0.262906766423922
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,14631,263,0.99 [0.77-1.27],0.9391259207929116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,14583,261,0.95 [0.74-1.22],0.6768335192567609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,16485,311,0.88 [0.68-1.13],0.3261166167193822
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,14258,257,0.84 [0.62-1.15],0.2870278260861536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,14613,264,0.85 [0.53-1.35],0.4863633284321536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,16426,308,0.94 [0.77-1.14],0.5034253573134033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,14373,259,1.05 [0.92-1.21],0.4512196029919605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,16744,318,0.82 [0.63-1.05],0.1201477518980618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,16744,318,0.83 [0.64-1.06],0.1390713692709863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,16938,322,0.98 [0.83-1.16],0.8042230658866568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,14583,261,1.02 [0.74-1.40],0.920902624907705
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,16991,324,1.17 [0.85-1.60],0.337144206198288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,16426,308,1.13 [0.95-1.36],0.1745767830373805
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,16709,313,1.23 [0.88-1.71],0.2329461935469583
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,16485,311,1.06 [0.84-1.35],0.6204722896841716
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,14583,261,1.06 [0.81-1.37],0.6796732553876732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LXN,Latexin,16564,314,0.91 [0.79-1.06],0.2372905816781458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,16717,313,1.06 [0.82-1.37],0.6574918934594618
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,16744,318,1.04 [0.80-1.35],0.7633367915768745
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,16568,317,1.37 [0.97-1.93],0.0736789109813859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,16635,316,0.88 [0.66-1.16],0.3574554216909539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,16426,308,0.84 [0.68-1.05],0.120409072539703
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,16705,317,0.99 [0.88-1.12],0.915428527294721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,16402,318,0.93 [0.78-1.10],0.3972101065588844
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,16703,320,0.87 [0.65-1.18],0.3804365567670384
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,16426,308,0.80 [0.64-0.99],0.0411652316261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,14190,256,0.95 [0.84-1.07],0.3599876219255115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,14258,257,1.03 [0.92-1.15],0.629432709175699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,14658,262,1.04 [0.57-1.89],0.9051585546872952
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,14130,252,0.89 [0.63-1.25],0.4962500390660705
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,14339,253,0.98 [0.82-1.16],0.8162145510688141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,14270,256,0.95 [0.69-1.31],0.7590173190032572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,16572,316,0.95 [0.76-1.17],0.6125520444281025
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,16426,308,0.85 [0.65-1.13],0.267711753422109
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,14258,257,0.96 [0.75-1.23],0.7646043179261527
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,14373,259,0.93 [0.82-1.06],0.2582749519864664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,16426,308,0.90 [0.72-1.12],0.3493846612695956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,14631,263,0.95 [0.68-1.31],0.7391380688030407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,14583,261,1.09 [0.88-1.34],0.4391946731936456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",14270,256,1.55 [0.96-2.51],0.0736933747000303
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,14631,263,1.01 [0.83-1.23],0.9416911062875144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",14130,252,1.00 [0.79-1.28],0.9901514021270758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,16845,315,0.96 [0.89-1.04],0.3620084798101325
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,16846,321,1.02 [0.72-1.46],0.9001141341250947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,14169,257,0.97 [0.82-1.15],0.7430010159031896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,14190,256,0.81 [0.56-1.19],0.2938910195513309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,14169,257,1.16 [1.01-1.33],0.038964287350179
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,14621,264,1.08 [0.84-1.39],0.5681340475569747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,14571,263,0.95 [0.79-1.15],0.601677391235204
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,16744,318,0.98 [0.89-1.08],0.7073086534051918
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,16426,308,0.99 [0.89-1.10],0.9054526727248609
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,16606,316,0.98 [0.90-1.08],0.7107424239604658
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,14130,252,0.94 [0.70-1.26],0.678708812851158
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,16744,318,0.98 [0.77-1.25],0.8801183612836554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,14373,259,0.93 [0.79-1.10],0.3910336068813412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,14130,252,1.02 [0.94-1.11],0.5761033848743344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,16402,318,1.06 [0.87-1.28],0.5663937311828675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,16771,321,1.20 [0.82-1.77],0.3450250198150326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",14315,253,0.98 [0.85-1.13],0.780533034475904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,16606,316,1.38 [0.89-2.13],0.1448280386906633
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,16794,315,1.36 [0.97-1.91],0.0791776654736362
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,16607,316,1.12 [0.84-1.50],0.4472332560711072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,16426,308,0.98 [0.88-1.10],0.7429345656758619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MAX,Protein max,16402,318,0.98 [0.89-1.08],0.7404665837523297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,16991,324,1.31 [1.11-1.55],0.0015305270035003
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,14455,261,0.97 [0.87-1.08],0.5933514319095873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,16877,322,0.85 [0.63-1.15],0.3002432292742985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",14613,264,1.23 [0.95-1.58],0.1101038559803831
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,14204,254,0.98 [0.85-1.13],0.7848537091389718
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,16681,317,1.04 [0.83-1.31],0.731402279299026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,14571,263,0.71 [0.44-1.16],0.1736625488998227
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,16635,316,0.95 [0.82-1.10],0.4840705155683175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",14569,262,0.88 [0.65-1.20],0.4221786345269493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDK,Midkine,16803,320,1.02 [0.85-1.24],0.8186718591313084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,14258,257,1.17 [0.79-1.73],0.4286025066502519
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",14270,256,0.90 [0.79-1.03],0.1186465550801883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,16426,308,0.96 [0.84-1.09],0.5217866138484086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,14169,257,0.87 [0.66-1.15],0.3314968594249309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,16765,314,0.87 [0.67-1.13],0.2940181917826779
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,14169,257,1.05 [0.74-1.48],0.8021222176111542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,16953,324,0.98 [0.58-1.65],0.9405836966224242
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,14631,263,0.85 [0.57-1.26],0.4147897609396446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,14339,253,0.59 [0.35-0.98],0.0415340891918042
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,14571,263,1.10 [0.94-1.29],0.2493506539274771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,16771,321,0.92 [0.85-1.00],0.0580682003738221
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,16765,314,0.91 [0.61-1.36],0.6517951775065165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,16954,324,1.42 [0.96-2.09],0.0780635779507119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,16799,321,0.95 [0.88-1.04],0.2672248987001225
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,16834,320,1.07 [0.65-1.76],0.7979752627836051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,16402,318,0.90 [0.64-1.28],0.5599300634118838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",16744,318,0.93 [0.82-1.05],0.2255099553799201
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,16907,321,0.81 [0.68-0.97],0.0187327211131326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,16478,312,0.83 [0.66-1.04],0.1108812705566729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,14258,257,1.02 [0.85-1.22],0.818073622849508
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,14339,253,1.26 [0.87-1.82],0.2291035455229619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,16991,324,1.16 [0.91-1.47],0.2439583205215082
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,16799,321,1.33 [1.07-1.66],0.0114544259426608
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,16820,315,0.99 [0.88-1.11],0.8432554926914314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,16744,318,0.98 [0.90-1.06],0.6095949735195647
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,16846,321,1.18 [0.91-1.52],0.2174222627450449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,14258,257,0.97 [0.80-1.16],0.7100114191743111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,16744,318,1.02 [0.95-1.09],0.6355067549042027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,16776,320,0.84 [0.73-0.98],0.0221469677893499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,16485,311,1.08 [0.89-1.32],0.4275848951272906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,14583,261,0.95 [0.85-1.07],0.407435766465213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,14621,264,0.97 [0.86-1.11],0.6869316792094644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,16635,316,0.98 [0.89-1.09],0.7429984358531958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,14204,254,1.19 [0.90-1.58],0.2221355494843165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,14130,252,1.12 [0.95-1.32],0.1807081266904409
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,16744,318,1.11 [0.99-1.25],0.0697643938435869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,16705,317,1.06 [0.94-1.20],0.3295950317206928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,16166,314,1.01 [0.90-1.12],0.9228291489866762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,16735,315,1.05 [0.89-1.25],0.5491703734792981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,16803,321,1.22 [1.03-1.45],0.0222197676580574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,16402,318,1.05 [0.77-1.42],0.7596379788759677
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,14631,263,1.12 [0.90-1.40],0.3073288988502033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,16799,321,1.00 [0.82-1.22],0.992435769986094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,16452,312,1.42 [1.15-1.75],0.0012890202022589
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,16880,323,0.93 [0.81-1.07],0.3260006749992386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,16771,321,0.94 [0.80-1.11],0.4549048420065921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",14169,257,0.99 [0.78-1.27],0.962096702498431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,14258,257,0.99 [0.80-1.22],0.91904921444318
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,14373,259,0.83 [0.62-1.12],0.2250148668855275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,16741,320,0.90 [0.81-1.00],0.0533713710738628
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,14339,253,1.02 [0.84-1.23],0.8434387761921137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,16938,322,0.91 [0.68-1.22],0.5321273594451672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,14621,264,1.08 [0.71-1.65],0.7261894095846892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,14373,259,1.17 [0.89-1.54],0.257127742959077
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,14130,252,1.01 [0.74-1.39],0.9356056261599291
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,14130,252,1.12 [0.97-1.28],0.1184490839041505
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,16478,312,0.89 [0.77-1.02],0.0875467502681244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,16705,317,0.94 [0.84-1.06],0.347716174809309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,16820,315,0.95 [0.84-1.08],0.4412417567812434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,16799,321,0.90 [0.72-1.12],0.3478289790271203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,14548,261,1.18 [0.91-1.53],0.2061875371183548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,14649,262,1.48 [0.99-2.22],0.0583632745171343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,14258,257,0.85 [0.72-1.02],0.0746656718044914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",14169,257,1.12 [0.83-1.51],0.4596977595916399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",14613,264,1.04 [0.77-1.40],0.802187610105104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",16402,318,0.89 [0.61-1.29],0.5328769007342056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",14099,251,1.04 [0.68-1.59],0.8599863029796789
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",14613,264,1.02 [0.87-1.20],0.8011593581812072
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",14204,254,1.16 [0.78-1.71],0.4700319370684277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,16675,317,1.06 [0.90-1.24],0.4981188874699236
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,14258,257,1.20 [0.90-1.60],0.2133531030650474
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,16753,321,1.11 [0.96-1.27],0.1461624014217883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,16913,324,1.11 [0.89-1.37],0.3540072281731499
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,16846,321,0.94 [0.82-1.08],0.4198068524679957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,14414,260,0.95 [0.81-1.12],0.5368463561552532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,16478,312,1.01 [0.83-1.22],0.9436993265003666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,14204,254,0.94 [0.83-1.08],0.389441758435756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",14621,264,1.18 [0.75-1.86],0.4652183060020393
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,14373,259,1.00 [0.90-1.11],0.9955851742591482
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",14571,263,0.91 [0.80-1.05],0.1907247943107828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,16478,312,1.10 [0.83-1.47],0.4987214148865911
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,14169,257,1.13 [0.96-1.33],0.1326000097642447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,14571,263,1.03 [0.93-1.14],0.5998531045587203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,14583,261,1.00 [0.89-1.13],0.9455934175539312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,14373,259,1.03 [0.83-1.27],0.8179487532599592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,16402,318,1.09 [0.90-1.32],0.3753762201874246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,16705,317,1.04 [0.99-1.10],0.1452010439418084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,14647,266,0.98 [0.86-1.11],0.7324445736080649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,14130,252,1.11 [0.86-1.44],0.4182640171615875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,16485,311,1.06 [0.93-1.20],0.3716330673869387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,14339,253,0.70 [0.47-1.03],0.071037670507212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",14631,263,1.31 [1.13-1.52],0.0004005202682256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",14270,256,1.04 [0.90-1.19],0.589200787419978
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,14613,264,0.89 [0.73-1.07],0.2140159276840543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,14631,263,0.99 [0.88-1.12],0.8766282501165354
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,14169,257,0.86 [0.64-1.15],0.303567774312116
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,14130,252,1.00 [0.75-1.32],0.9831693712245394
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,14647,266,0.96 [0.86-1.06],0.3851183698278452
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",14169,257,1.16 [0.86-1.55],0.3333697414100403
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,14270,256,1.25 [1.07-1.46],0.0057594400962574
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,14270,256,0.77 [0.60-0.99],0.0412044955537619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,14258,257,1.00 [0.88-1.15],0.9419121314154358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",14258,257,1.16 [0.94-1.43],0.178113969361021
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,14613,264,0.85 [0.60-1.19],0.3422590097756914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,16485,311,0.97 [0.83-1.13],0.6640359433284496
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,16799,321,0.90 [0.72-1.12],0.3411200117325269
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,14190,256,1.34 [1.11-1.61],0.0022217172492776
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,14169,257,1.20 [0.96-1.49],0.1093217981191768
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,14339,253,1.25 [1.10-1.43],0.000523744821821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,16819,315,1.03 [0.85-1.25],0.7910078456936416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,16426,308,1.04 [0.85-1.26],0.7328458948658216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,14169,257,1.03 [0.81-1.30],0.824240587800579
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,14258,257,1.00 [0.91-1.11],0.9455800335120764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,16560,316,0.84 [0.70-0.99],0.0415321350890428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,14583,261,1.08 [0.88-1.33],0.4756840126168751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,16771,321,0.89 [0.73-1.07],0.2028795118468726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,14171,253,1.05 [0.85-1.30],0.6377988483016737
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,14243,256,0.97 [0.77-1.20],0.7590348684091791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,14339,253,1.25 [0.71-2.20],0.438935988214121
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,16426,308,0.91 [0.74-1.11],0.3421920275933998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,14540,262,0.80 [0.61-1.05],0.1089204053434181
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,14621,264,0.87 [0.61-1.25],0.4587553780536314
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",14613,264,0.95 [0.74-1.22],0.6764423797661958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,16846,321,1.20 [0.83-1.72],0.3297196356933709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,16485,311,0.81 [0.65-1.01],0.0651830331014047
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,16877,322,1.19 [0.87-1.63],0.2753084345938814
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,16799,321,0.94 [0.65-1.35],0.7382456197675398
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,16913,324,1.07 [0.83-1.39],0.5912718051411598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,16718,318,0.86 [0.76-0.98],0.0227363150559321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,16845,315,0.99 [0.90-1.08],0.7696072099359281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,16485,311,1.05 [0.86-1.27],0.6433670340040031
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,16718,317,0.99 [0.76-1.29],0.9626067960932057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,14571,263,1.31 [0.94-1.83],0.1101639551758018
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,16938,322,1.65 [1.18-2.31],0.0032377692319234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,16402,318,1.01 [0.87-1.18],0.8574339871167902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,14583,261,0.94 [0.77-1.15],0.5301081359431692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,14186,254,1.26 [0.90-1.77],0.1803539578445324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,14571,263,0.95 [0.83-1.09],0.4629558490145098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",16426,308,1.01 [0.89-1.15],0.8375510474494878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,14169,257,1.12 [0.83-1.51],0.4464692365067075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,14169,257,1.00 [0.84-1.20],0.9866456419130454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,14204,254,1.05 [0.73-1.50],0.8030462013273957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,16745,321,1.28 [0.94-1.76],0.1212524639193155
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,16846,321,1.27 [0.95-1.71],0.1068800897360126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,14204,254,0.88 [0.69-1.12],0.2896906595045254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,14204,254,0.92 [0.64-1.34],0.6769733793921213
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,16346,316,1.12 [0.91-1.39],0.2841410330746891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,14373,259,1.04 [0.89-1.22],0.6170992394109382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,16846,321,0.87 [0.69-1.10],0.2348984823021595
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,16845,315,1.35 [0.97-1.88],0.0769257996532043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,14583,261,0.97 [0.87-1.08],0.5658876937421907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,14613,264,0.95 [0.56-1.61],0.8508861325103626
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,14649,262,0.99 [0.83-1.18],0.900973062630382
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,16954,324,1.72 [1.24-2.40],0.0012851434326097
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,14204,254,1.00 [0.86-1.15],0.9692261187186286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",16744,318,1.01 [0.91-1.12],0.8577465071131243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",16485,311,1.15 [0.98-1.35],0.0797367293824621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,14270,256,0.93 [0.78-1.10],0.3745979293231503
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,14613,264,0.87 [0.64-1.19],0.3882373977456855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,14169,257,0.99 [0.84-1.17],0.9170424752066434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,14373,259,1.02 [0.83-1.26],0.8428099884944176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,16426,308,0.97 [0.78-1.20],0.7710702417299928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",14571,263,0.94 [0.84-1.06],0.2938697197487017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,14169,257,0.95 [0.79-1.14],0.5859520491341246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,14169,257,0.77 [0.54-1.09],0.1421559775525076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,16635,316,1.14 [0.51-2.56],0.7550019704419986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,14631,263,1.06 [0.71-1.57],0.7771210046273773
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,14621,264,1.23 [0.76-2.01],0.3944070144857803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,13977,252,1.39 [0.94-2.07],0.1003382307482405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,16816,321,0.98 [0.75-1.28],0.8640745396463785
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,16799,321,0.94 [0.82-1.07],0.3295607777039585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,16426,308,1.03 [0.85-1.24],0.7549999850077405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,14270,256,0.87 [0.67-1.12],0.2788545332624194
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,14578,262,0.93 [0.79-1.10],0.3840208933194269
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,14258,257,0.97 [0.80-1.16],0.7128873055987479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,14190,256,1.07 [0.85-1.36],0.5625010831458033
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,14204,254,1.17 [0.67-2.05],0.5876127839529953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,16794,315,0.97 [0.63-1.49],0.8771466370707656
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,14533,261,0.95 [0.80-1.13],0.5897653271217848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,16635,316,0.83 [0.71-0.96],0.0116678939395597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,14130,252,0.92 [0.66-1.28],0.6331577081223629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,14613,264,0.92 [0.76-1.11],0.384394237919453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,16799,321,1.39 [0.91-2.15],0.1318099166225107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,14169,257,1.09 [0.98-1.20],0.0976481838211372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",16402,318,1.11 [0.93-1.32],0.260121822883115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",14169,257,0.97 [0.71-1.32],0.8513026984933958
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",16402,318,1.15 [0.96-1.37],0.1223584831082812
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,16991,324,1.28 [0.69-2.39],0.4359316372678887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,14647,266,1.19 [0.68-2.08],0.5444160504948102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,16991,324,0.82 [0.61-1.11],0.2025753583929684
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,14401,265,1.31 [0.92-1.86],0.1367491553137876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,16771,321,1.11 [0.83-1.50],0.4804210398414049
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,14204,254,0.74 [0.51-1.07],0.1119329541422161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,14204,254,1.07 [0.96-1.20],0.1966052057000708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,14631,263,0.96 [0.74-1.25],0.7696061043241849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,16478,312,0.96 [0.90-1.03],0.2680644696298457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,16744,318,1.05 [0.87-1.28],0.6103624539749959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,14169,257,1.03 [0.76-1.39],0.8392839699006309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,16426,308,1.00 [0.88-1.14],0.9548082952909078
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,16799,321,1.29 [1.02-1.63],0.0321028358264645
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,14647,266,1.13 [0.79-1.62],0.4958839164469767
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,16771,321,0.93 [0.69-1.24],0.619456850021594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,16938,322,1.03 [0.89-1.21],0.663952217780364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,16771,321,1.53 [1.10-2.14],0.0113821261586741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,14649,262,1.00 [0.88-1.14],0.9953181073591006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,14613,264,0.98 [0.70-1.38],0.9167779133554068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,16900,322,1.59 [1.11-2.27],0.011261933570487
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,16799,321,1.31 [0.93-1.84],0.1257004063349448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,16485,311,0.93 [0.75-1.14],0.4805158104389234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,14258,257,0.92 [0.65-1.31],0.6446365681092756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,16913,324,0.84 [0.72-0.97],0.0210536983756115
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",14631,263,1.01 [0.86-1.19],0.8910648719460749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,14621,264,1.29 [0.92-1.81],0.1388321435153696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,16719,317,0.91 [0.81-1.02],0.0965467539688304
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,16846,321,0.88 [0.72-1.06],0.1802532149007878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,16744,318,0.79 [0.60-1.06],0.1148988819107982
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,16426,308,1.00 [0.75-1.32],0.9749615042688172
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,16771,321,0.90 [0.61-1.34],0.6136347342582449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,16913,324,0.90 [0.57-1.42],0.6375152926959131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,16771,321,0.95 [0.88-1.04],0.2913512954160824
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,16744,318,0.99 [0.87-1.11],0.8070164137777603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,14583,261,1.07 [0.95-1.20],0.2748998846309707
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,16904,322,1.02 [0.78-1.34],0.8710306932202283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,16954,324,0.98 [0.83-1.14],0.7510673822202255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,14270,256,0.85 [0.51-1.42],0.5338082660097947
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,14169,257,0.89 [0.69-1.14],0.3567750514148778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,14541,262,0.97 [0.85-1.12],0.6800036436913863
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],16705,317,0.89 [0.74-1.07],0.2199825917879372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,16799,321,1.02 [0.84-1.25],0.8334357371101312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,14204,254,0.98 [0.85-1.14],0.7983498985579189
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,14169,257,0.51 [0.32-0.83],0.0060733903895869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,14169,257,1.09 [0.76-1.56],0.6510197804372712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,16402,318,0.97 [0.75-1.25],0.8137446657437835
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,14204,254,1.06 [0.71-1.59],0.7786940172589801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,16587,316,0.84 [0.71-0.99],0.040858484668243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,14613,264,1.31 [1.01-1.69],0.0390982414162336
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,16378,317,1.11 [0.94-1.31],0.2383671273972702
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,14373,259,0.98 [0.81-1.19],0.836717953142926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,14571,263,0.97 [0.81-1.15],0.6892590220991575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,16705,317,0.91 [0.66-1.25],0.556090539632454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,16799,321,1.28 [1.02-1.60],0.0300632546019507
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,14373,259,1.04 [0.87-1.25],0.6658529466457445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,13782,245,0.97 [0.87-1.07],0.5003473310181649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,16616,318,0.93 [0.78-1.11],0.4166911002050011
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,16845,315,1.05 [0.82-1.34],0.6862597745529989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,16705,317,0.92 [0.80-1.07],0.2765850068220249
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,14190,256,0.76 [0.57-1.01],0.054894494685724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,14621,264,0.99 [0.88-1.10],0.7930200012550847
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,14270,256,0.96 [0.80-1.15],0.675661701762279
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,16705,317,0.89 [0.71-1.12],0.3111880930389634
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,14602,261,1.00 [0.55-1.82],0.9983521035033036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,14621,264,1.17 [0.89-1.52],0.2580654147705881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,16794,315,1.34 [1.00-1.79],0.0479239135130326
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,16679,318,0.95 [0.82-1.10],0.4985298117414969
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,16900,322,0.99 [0.60-1.64],0.9640522573151128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,14258,257,1.07 [0.81-1.42],0.6454423185201165
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,14190,256,1.06 [0.85-1.32],0.5925966256714412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,14571,263,0.91 [0.74-1.12],0.3744553367528869
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,14613,264,1.01 [0.84-1.22],0.9074920842810554
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",14270,256,0.96 [0.80-1.15],0.648534655820544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,16913,324,1.01 [0.95-1.08],0.717062582178614
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,16710,319,0.95 [0.73-1.23],0.6840695711720904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,14169,257,0.97 [0.79-1.18],0.7541076893473655
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,16485,311,1.01 [0.85-1.21],0.9104313567189678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,16378,317,0.84 [0.72-0.98],0.0224723548730983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,16635,316,0.98 [0.89-1.09],0.7267532244449748
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,14613,264,1.05 [0.95-1.15],0.3618374038477928
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",14373,259,0.94 [0.74-1.20],0.6350925918087826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,16478,312,0.97 [0.81-1.17],0.7394909769400762
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,14270,256,0.74 [0.54-1.01],0.0606476596497696
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,14108,252,0.98 [0.77-1.25],0.8817511922179228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,16402,318,0.93 [0.78-1.10],0.3707089481835365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,14204,254,1.28 [0.99-1.65],0.0580285709092386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,14485,262,0.90 [0.62-1.32],0.5978853374429074
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,14621,264,1.14 [0.83-1.57],0.4057129456622945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,14169,257,1.02 [0.87-1.20],0.7657051496794792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,16906,322,1.17 [0.82-1.66],0.3967447390321794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,16799,321,0.87 [0.60-1.26],0.4525290626460122
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,16485,311,0.84 [0.67-1.04],0.1037959045528254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,14373,259,1.00 [0.86-1.17],0.9704885490378096
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,16799,321,0.86 [0.70-1.04],0.1145851586857008
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,16744,318,0.96 [0.80-1.16],0.6853069034302492
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,14339,253,0.98 [0.75-1.29],0.9056127842518962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,14130,252,0.97 [0.66-1.43],0.887681964891161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,16402,318,1.01 [0.83-1.23],0.9132921731560706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,14571,263,0.96 [0.64-1.44],0.8305986511160888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,14190,256,1.09 [0.96-1.23],0.1988133160432257
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,14315,253,1.04 [0.80-1.36],0.7681533303418739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,14613,264,0.97 [0.82-1.14],0.6713581260166347
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,16901,323,1.41 [0.91-2.19],0.1241280477363149
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,14613,264,1.32 [0.83-2.09],0.2354385379797945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,16771,321,1.11 [0.85-1.46],0.4355669928972417
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,14571,263,0.81 [0.56-1.17],0.254379555987372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,14571,263,0.99 [0.70-1.40],0.9743972896375842
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,14583,261,0.86 [0.64-1.16],0.3187144233457018
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,14130,252,0.94 [0.76-1.15],0.5236534854945004
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,14583,261,1.04 [0.81-1.32],0.7679086647030052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,16991,324,1.03 [0.80-1.31],0.839638876737512
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,14571,263,1.01 [0.86-1.18],0.9358180197366568
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,14631,263,0.95 [0.84-1.07],0.4006164615070567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,16908,321,1.19 [0.94-1.49],0.1420821665555053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,16705,317,1.27 [0.93-1.73],0.1252984315737233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,16913,324,0.85 [0.72-1.01],0.0694381624630208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,16771,321,0.89 [0.79-1.00],0.0584063364595689
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,14130,252,0.98 [0.77-1.25],0.8918968652818999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",14130,252,0.98 [0.78-1.23],0.8499862314994799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",14169,257,1.04 [0.85-1.26],0.7321677158531567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",14339,253,0.98 [0.87-1.10],0.7357158112383226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,16991,324,0.93 [0.82-1.07],0.313444704016983
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,16845,315,0.94 [0.84-1.05],0.2738394644178502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,16426,308,1.24 [0.86-1.78],0.2406529510287638
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,16771,321,0.98 [0.69-1.39],0.9076050352710386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,16991,324,1.07 [0.81-1.43],0.6246590802883589
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,14130,252,0.77 [0.56-1.07],0.1243950581323623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,14339,253,1.22 [0.76-1.97],0.4067524942455113
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,14647,266,0.94 [0.77-1.14],0.5173483691915817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,14130,252,1.05 [0.86-1.28],0.6147992710348719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,14613,264,0.98 [0.89-1.09],0.7278804423471845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,16845,315,1.01 [0.93-1.09],0.851563690528414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",16426,308,1.05 [0.86-1.28],0.6609942588273281
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,14258,257,0.94 [0.74-1.20],0.6230478668385497
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,14130,252,1.08 [0.89-1.32],0.4162223297385153
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,14169,257,0.97 [0.79-1.20],0.7924125279734411
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,14204,254,1.55 [1.22-1.97],0.0003916244732247
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,16991,324,1.21 [0.79-1.87],0.3788185003196939
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,16799,321,0.86 [0.72-1.03],0.0932601834873253
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,16799,321,0.88 [0.63-1.22],0.4434901090457948
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,14270,256,0.63 [0.39-1.03],0.0669768645652535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,14339,253,1.01 [0.69-1.47],0.9779312955470876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,14649,262,0.86 [0.55-1.36],0.5276482092831511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,14204,254,1.02 [0.93-1.13],0.6212735587246305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,14553,260,0.98 [0.87-1.11],0.8023114602878603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,16402,318,1.01 [0.84-1.21],0.8982480566576706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,14130,252,1.09 [0.88-1.37],0.4247350719526023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,14258,257,1.02 [0.85-1.22],0.8572243644626858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",16672,316,0.96 [0.84-1.09],0.5391457208527015
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,14649,262,1.11 [0.96-1.28],0.1615299608949067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",14631,263,0.94 [0.75-1.18],0.5830142802550327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,16954,324,1.32 [0.91-1.92],0.1498003114494071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,16930,323,0.97 [0.77-1.22],0.7773239048551379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,14480,262,1.03 [0.69-1.54],0.8812678767318484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,14169,257,1.08 [0.89-1.31],0.4518903917386127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,14258,257,1.06 [0.88-1.28],0.5317163389320051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,14204,254,1.02 [0.91-1.15],0.7152034354276818
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,14613,264,0.96 [0.87-1.07],0.4496442538678816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,14571,263,1.32 [1.05-1.65],0.0166273854074536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,14130,252,0.97 [0.84-1.10],0.6074381478653493
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,16635,316,1.22 [0.87-1.71],0.2513319462765379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,14339,253,0.96 [0.71-1.29],0.7890452900408792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,14649,262,1.07 [0.66-1.73],0.7822075621125558
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PI3,Elafin,16592,320,1.14 [0.96-1.35],0.1290808202661665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",14613,264,1.01 [0.87-1.18],0.8970793901666133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,16585,319,1.54 [1.18-2.00],0.0015692681579763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,16744,318,0.89 [0.76-1.05],0.1845295406049038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,16799,321,1.26 [0.91-1.76],0.165545155058902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,14204,254,1.04 [0.84-1.29],0.7383817853211427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,16799,321,1.01 [0.80-1.27],0.9590734659253854
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,16771,321,0.93 [0.79-1.11],0.4228989877206019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,14339,253,1.04 [0.87-1.24],0.6595908534615176
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,14108,252,1.03 [0.88-1.20],0.7163285981873377
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,14631,263,0.98 [0.63-1.54],0.9411021885809838
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,14169,257,1.05 [0.85-1.30],0.6341697181702931
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,16802,314,0.80 [0.68-0.94],0.0055800501257674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,14373,259,0.97 [0.82-1.14],0.7195461230532872
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,16635,316,1.12 [0.94-1.33],0.1991928659679878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,16846,321,1.06 [0.73-1.53],0.769825165129245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,16971,324,1.13 [0.91-1.40],0.2770704292480425
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",16754,318,1.09 [0.92-1.31],0.3226457250575371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,16845,315,1.00 [0.89-1.12],0.9610825277108735
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,16799,321,0.70 [0.52-0.93],0.0134627399502799
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,16953,324,1.12 [0.92-1.36],0.253770715103925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,16799,321,0.84 [0.59-1.20],0.3477106730224738
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,16674,314,1.20 [0.84-1.72],0.3168014363560832
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",14621,264,0.78 [0.64-0.95],0.0135352013458196
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",14204,254,0.98 [0.72-1.32],0.8890294503381361
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",14621,264,0.97 [0.86-1.10],0.640208290151686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,14621,264,1.01 [0.85-1.20],0.9187888285092708
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,14301,260,0.89 [0.51-1.56],0.6832349807367212
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,16402,318,1.07 [0.81-1.41],0.6518834853966371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,16771,321,1.00 [0.79-1.27],0.9978684247831774
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,16771,321,0.89 [0.77-1.04],0.1325432857523161
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,14592,262,1.04 [0.84-1.28],0.7379422645198443
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,16939,323,0.82 [0.63-1.07],0.1464114927207593
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,16426,308,0.93 [0.67-1.29],0.6693903069866585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,14621,264,1.34 [0.93-1.94],0.1157929214523906
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,16744,318,0.94 [0.84-1.07],0.3466007087174337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,16923,323,1.38 [0.92-2.06],0.1150903743196729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,16724,321,1.02 [0.83-1.26],0.8574639156623556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,16682,319,1.01 [0.96-1.07],0.6864790413934166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,14169,257,0.91 [0.77-1.08],0.269614066543268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,14169,257,1.01 [0.82-1.23],0.9553360834702606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,14258,257,1.12 [0.90-1.39],0.3159232020402117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,16373,318,0.93 [0.85-1.01],0.0997670217493193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,14649,262,1.09 [0.91-1.31],0.3414424443736147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,14621,264,1.11 [0.96-1.28],0.1505226425178307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,16765,314,1.00 [0.96-1.03],0.808891731673927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,14270,256,0.87 [0.70-1.09],0.2220065542384297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,14190,256,1.01 [0.77-1.31],0.964968706656428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",16485,311,0.98 [0.90-1.08],0.7367463209261422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,16705,317,0.86 [0.45-1.65],0.6575695394503726
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,16846,321,1.02 [0.71-1.45],0.9236787997761984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,14204,254,1.16 [0.90-1.49],0.2582664448420337
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,14204,254,0.83 [0.54-1.28],0.4035618381560575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",16705,317,0.95 [0.70-1.28],0.7194418865665988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,14270,256,1.14 [0.96-1.35],0.1487004936680873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,14649,262,0.97 [0.64-1.48],0.890329191838002
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,16478,312,1.54 [1.16-2.04],0.0026720333829131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,16845,315,1.02 [0.72-1.45],0.8954967211866216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,14647,266,0.72 [0.53-0.99],0.0449241945073783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,14557,261,0.99 [0.86-1.14],0.9005415193431108
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,16913,324,0.88 [0.71-1.09],0.2279687243530781
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,16821,321,0.95 [0.86-1.06],0.3542676674264819
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,14373,259,0.94 [0.77-1.15],0.5337240581370408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",14647,266,0.90 [0.74-1.10],0.3126942183528875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,14204,254,1.00 [0.69-1.45],0.997131589712425
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,16426,308,0.86 [0.61-1.21],0.381896760290532
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,14204,254,1.03 [0.84-1.25],0.785683685534058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,14631,263,0.93 [0.74-1.17],0.5302712369102063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,16705,317,0.82 [0.70-0.97],0.0196919175430828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,14583,261,0.96 [0.83-1.11],0.6014868369701973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,16846,321,0.95 [0.86-1.06],0.3717289235824927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,14373,259,0.91 [0.76-1.10],0.3263576407334898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,14613,264,0.90 [0.77-1.06],0.2064195216811949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,14613,264,1.22 [0.93-1.59],0.1452389089644807
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,16771,321,0.95 [0.84-1.08],0.4430167790570167
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,16954,324,0.99 [0.90-1.10],0.9022769072651442
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,14571,263,1.01 [0.92-1.12],0.7695885819106536
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,16635,316,0.95 [0.74-1.22],0.7140507300342321
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,14258,257,0.98 [0.83-1.15],0.7744555185912678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,16778,318,1.05 [0.96-1.16],0.273340556623875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,16426,308,1.00 [0.83-1.20],0.9918325429959416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,14130,252,1.09 [0.67-1.76],0.7282671079066154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,14647,266,1.14 [0.84-1.54],0.410039899954427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,14583,261,0.78 [0.56-1.10],0.1554400721307619
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,16905,323,1.40 [1.05-1.88],0.0235239848693307
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,16297,312,1.01 [0.90-1.13],0.9116126927907166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,14389,259,0.81 [0.67-0.99],0.0370061730822612
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",16485,311,0.93 [0.81-1.07],0.3225226362773447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",16954,324,0.89 [0.77-1.03],0.1093130360114162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,16938,322,0.86 [0.73-1.01],0.066267889650985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,16485,311,0.92 [0.65-1.32],0.6671976020908126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,16765,314,0.93 [0.61-1.42],0.7296766457178758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,14647,266,0.93 [0.74-1.17],0.5386351765470558
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,14647,266,0.82 [0.64-1.04],0.1012293773949772
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,16485,311,0.98 [0.81-1.19],0.848417550990388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,14258,257,0.70 [0.47-1.07],0.0983832734359147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,16771,321,0.93 [0.82-1.04],0.2051187376119093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,14590,263,0.96 [0.83-1.12],0.5976134942922986
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,16485,311,1.09 [0.87-1.35],0.457131492178453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,14169,257,0.97 [0.73-1.29],0.8408594457447551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,14339,253,0.96 [0.87-1.06],0.4128119000632162
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,16426,308,1.02 [0.88-1.18],0.8203891933259666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,16913,324,1.05 [0.93-1.20],0.4238686317735264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,14621,264,1.17 [0.93-1.47],0.1844572495667607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,16846,321,1.12 [0.75-1.66],0.5846457209141371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,14169,257,0.89 [0.60-1.31],0.5545228602113533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,16744,318,0.98 [0.81-1.19],0.8395301032663953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,14658,262,1.06 [0.67-1.69],0.798016826521391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,14229,253,1.09 [0.92-1.29],0.3284631086223254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,14204,254,1.33 [1.06-1.66],0.0122113432415024
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,14270,256,1.05 [0.76-1.44],0.7633714827918552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,16877,322,1.19 [1.00-1.41],0.0461220638436936
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,14204,254,1.34 [1.00-1.79],0.0504144439171137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,16734,321,0.90 [0.70-1.16],0.4316054046504921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,14621,264,1.07 [0.78-1.47],0.6830849324097064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,16728,314,1.23 [0.97-1.56],0.0849699424096043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,16402,318,0.96 [0.88-1.05],0.4285399143136777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,16938,322,0.96 [0.65-1.43],0.8549217028257264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,16364,315,0.86 [0.69-1.07],0.1761063388028643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,14373,259,1.13 [0.77-1.65],0.5446205292450237
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,14510,266,1.16 [0.77-1.77],0.4733188773533117
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,14571,263,0.81 [0.63-1.03],0.0789309350940603
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,14571,263,1.06 [1.01-1.11],0.0227062768990059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,16635,316,0.96 [0.88-1.04],0.3056505008912666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,16744,318,0.93 [0.79-1.10],0.4135408410747239
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,16426,308,1.01 [0.81-1.26],0.9350589092413408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,14130,252,0.85 [0.57-1.27],0.428947141090095
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,14613,264,0.78 [0.60-1.00],0.0501948619729244
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,14258,257,1.10 [0.90-1.34],0.353419858631387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,16705,317,0.80 [0.66-0.97],0.0221213144067567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,16602,316,0.79 [0.60-1.03],0.0858113813986887
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,16558,314,0.83 [0.63-1.09],0.1853663258973715
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,16744,318,0.79 [0.65-0.96],0.0172674066980214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,14204,254,0.80 [0.63-1.00],0.0464961011386248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,16744,318,0.97 [0.87-1.08],0.5605674689576741
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,16426,308,1.01 [0.85-1.19],0.9299874481928248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,13861,246,0.96 [0.86-1.08],0.5027723230124973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",16402,318,0.97 [0.70-1.35],0.8676395366444365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,16686,318,1.16 [0.85-1.58],0.3379906011822062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,14094,252,1.04 [0.83-1.30],0.7450004499108112
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,14631,263,1.02 [0.88-1.17],0.8079000496678306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,14258,257,0.95 [0.81-1.10],0.4843760772555044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,16744,318,0.88 [0.66-1.17],0.3733539227194871
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,16402,318,0.88 [0.68-1.15],0.3596954947252262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,16478,312,1.09 [0.89-1.34],0.3901386629576283
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,14204,254,0.99 [0.78-1.25],0.9028882654138756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,16635,316,0.96 [0.85-1.10],0.5646688032071177
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,16820,315,0.94 [0.84-1.05],0.248960531865721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,14182,253,1.06 [0.78-1.44],0.7127960238849534
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,14631,263,1.00 [0.67-1.50],0.9900125136827777
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,14647,266,0.75 [0.44-1.28],0.2959546734561746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,16991,324,0.81 [0.58-1.13],0.2075331743396826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,14571,263,1.17 [0.92-1.49],0.2023022276179041
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,14571,263,0.95 [0.54-1.67],0.8685234679159055
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,16719,316,1.16 [0.77-1.76],0.4720297132294067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,16584,315,1.04 [0.77-1.40],0.791897985550468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,14621,264,0.84 [0.61-1.15],0.2820416641654791
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,16991,324,0.79 [0.54-1.18],0.2483803954869339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,14631,263,1.44 [1.01-2.07],0.046891536577229
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,14339,253,0.89 [0.72-1.09],0.2594393334908416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,16326,317,1.03 [0.86-1.24],0.7514458536039644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,14373,259,0.90 [0.67-1.21],0.4879448493989364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,16744,318,0.99 [0.81-1.21],0.8909294179705062
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,16843,320,0.97 [0.89-1.06],0.496871526672043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,16913,324,1.03 [0.79-1.35],0.8081378751981186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,14583,261,0.97 [0.78-1.20],0.7531866612287866
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,16402,318,0.93 [0.76-1.13],0.4638437606332057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,14270,256,0.76 [0.55-1.04],0.0890659926976521
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,14169,257,1.16 [1.04-1.30],0.00791079508588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,14658,262,0.94 [0.71-1.24],0.6508563138145786
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,16698,321,0.85 [0.67-1.08],0.1927477666043908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,16845,323,1.18 [0.82-1.71],0.3796448728412243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,14371,257,1.15 [0.89-1.50],0.2850895802819597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,14631,263,0.91 [0.72-1.14],0.3962560455901006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,14631,263,1.00 [0.89-1.11],0.9543455278380912
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,14631,263,0.95 [0.83-1.10],0.521056097188036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,14583,261,0.95 [0.77-1.15],0.5823857229711715
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,14169,257,1.07 [0.89-1.28],0.4656746986450449
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,16485,311,1.01 [0.89-1.15],0.8711952725466036
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,14169,257,0.96 [0.83-1.11],0.5747747688821898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,14190,256,0.95 [0.77-1.19],0.6644067054994643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,14583,261,1.01 [0.77-1.32],0.9662451800545588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,16744,318,0.77 [0.62-0.97],0.0233340758660052
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,16402,318,1.11 [0.92-1.35],0.268908754443106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,14339,253,0.93 [0.79-1.10],0.4012506625804753
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,16426,308,0.96 [0.80-1.15],0.6683559563785171
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,16485,311,0.92 [0.77-1.09],0.3488725744975621
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,14258,257,0.93 [0.77-1.12],0.4527873632173416
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,16426,308,0.95 [0.76-1.19],0.6572559293263758
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,14373,259,0.99 [0.79-1.23],0.9008949388243316
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,14204,254,1.30 [0.87-1.93],0.2001372506238466
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,14583,261,1.08 [0.85-1.37],0.5151496189520092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,14270,256,0.76 [0.61-0.97],0.0246709384866273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,14190,256,0.83 [0.57-1.22],0.3435484029868642
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,16426,308,1.10 [0.89-1.35],0.3896620406193006
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,14204,254,1.05 [0.89-1.24],0.5281714286098561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,14373,259,0.97 [0.77-1.23],0.8121511425709119
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,16426,308,1.13 [0.86-1.49],0.3778455239513348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,16900,322,1.14 [0.93-1.39],0.2148852943588264
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,16402,318,1.00 [0.74-1.35],0.9791483156441476
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,14130,252,0.86 [0.64-1.14],0.2936212368610234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,16426,308,0.92 [0.76-1.12],0.4191982591152464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,14613,264,1.25 [0.94-1.67],0.1224675593445886
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,16374,316,0.86 [0.71-1.04],0.1090781908058297
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,14613,264,0.94 [0.80-1.09],0.4019998861197996
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,14169,257,0.92 [0.70-1.22],0.5758172440939837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,14130,252,0.97 [0.74-1.26],0.7922665714197246
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,14258,257,1.08 [0.92-1.26],0.3656064235707679
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,16705,317,1.09 [0.96-1.24],0.1687537319236131
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,16705,317,1.08 [0.90-1.30],0.3958873733195494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,14571,263,1.04 [0.86-1.26],0.6786195718937653
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,14204,254,1.09 [0.91-1.29],0.3449258907881392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,14270,256,0.96 [0.85-1.09],0.5437188372684439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,14583,261,1.03 [0.81-1.29],0.8352543019444816
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,16478,312,0.86 [0.65-1.13],0.2859800458574646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,14270,256,0.70 [0.40-1.25],0.2300045389522431
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,14613,264,1.15 [0.96-1.38],0.1402476730695879
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,16696,319,1.22 [1.02-1.47],0.0333727490102333
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,16991,324,1.17 [1.00-1.38],0.0506949821317481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,16991,324,1.11 [0.95-1.28],0.1822687490870012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,14583,261,1.12 [0.84-1.50],0.4388286060833101
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,16794,315,1.23 [1.02-1.48],0.0294448999623217
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,14204,254,0.92 [0.71-1.20],0.5465642411899945
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,16799,321,1.06 [0.76-1.48],0.7273386371711588
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REN,Renin,16771,321,1.09 [0.98-1.22],0.1110052551363178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,14204,254,0.89 [0.65-1.22],0.4682055723410127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,14130,252,1.10 [0.79-1.53],0.5737362200811007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,16705,317,1.00 [0.77-1.29],0.9994023604828892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RETN,Resistin,16762,321,0.98 [0.78-1.24],0.8685212624661358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",14169,257,0.98 [0.77-1.25],0.8828723116518111
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,14583,261,1.11 [0.63-1.96],0.7133090041302721
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,14613,264,0.97 [0.83-1.13],0.7058772415438942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,14373,259,1.01 [0.84-1.22],0.8900014632031904
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,16913,324,0.92 [0.68-1.25],0.604888596879392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,16913,324,0.93 [0.65-1.32],0.6759174413566444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,14613,264,1.01 [0.83-1.24],0.9036516895885038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,16485,311,1.10 [0.96-1.26],0.174311529097258
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,16535,316,0.97 [0.89-1.06],0.5309721102222402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,14204,254,1.03 [0.80-1.32],0.8227393133264312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,14339,253,0.97 [0.75-1.24],0.7948007723464514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,16879,321,0.86 [0.73-1.01],0.0673808056006911
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,14631,263,0.98 [0.87-1.10],0.7184260927618593
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,14169,257,1.06 [0.91-1.25],0.4444831456092746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,14613,264,1.09 [0.87-1.35],0.4647294772069263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,14310,252,1.25 [1.01-1.54],0.037205673419643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,14649,262,1.33 [0.87-2.04],0.1813944830878017
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,14270,256,0.97 [0.75-1.25],0.8267756374529769
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,16704,320,0.90 [0.81-0.98],0.0215255725531089
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,14156,253,1.49 [0.99-2.24],0.0585265537266848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,14539,260,1.00 [0.69-1.44],0.9940228678624312
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,14613,264,1.00 [0.79-1.28],0.9831166970401908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,16926,324,1.14 [0.79-1.64],0.4776020971919953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,14270,256,1.20 [0.82-1.76],0.3436484607347208
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,14204,254,1.04 [0.77-1.41],0.8130929762018959
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,14204,254,0.97 [0.68-1.37],0.8523479744914607
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,14373,259,1.08 [0.91-1.27],0.3838089509360317
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,16426,308,0.96 [0.82-1.12],0.6133186581204577
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,14373,259,1.01 [0.83-1.25],0.8950892297391275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,14270,256,0.87 [0.74-1.02],0.0901672163646513
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,16794,315,0.96 [0.63-1.46],0.855291817175556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,16913,324,1.00 [0.65-1.54],0.9893821895644386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,14270,256,1.27 [0.65-2.50],0.4838651578641668
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,16771,321,1.16 [0.85-1.58],0.3439361845203643
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,16705,317,0.91 [0.72-1.16],0.4394917442549843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,14204,254,1.09 [0.74-1.60],0.6685158788103046
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,14373,259,0.92 [0.77-1.09],0.3380957169877341
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,14258,257,0.87 [0.63-1.19],0.3794808866320045
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,14270,256,0.74 [0.53-1.05],0.0880830592872328
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,14169,257,0.78 [0.57-1.09],0.147306656346763
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,14258,257,1.01 [0.92-1.11],0.7781762352015296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,16426,308,1.11 [0.91-1.35],0.3053113068382451
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,16426,308,0.93 [0.80-1.08],0.3510412045942445
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,14190,256,1.02 [0.89-1.16],0.7703358278097282
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,16635,316,0.81 [0.60-1.09],0.1661362269593389
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,16938,322,1.04 [0.73-1.47],0.8306427341804561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,16705,317,0.75 [0.53-1.06],0.1048703560266803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,14169,257,0.93 [0.72-1.20],0.5562920014595623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",14613,264,0.90 [0.79-1.03],0.1189417353382502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,16938,322,1.50 [1.15-1.97],0.0031417648967182
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,16426,308,1.03 [0.93-1.13],0.5927226430887544
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,16913,324,0.92 [0.79-1.08],0.3014100365899666
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,14169,257,1.03 [0.74-1.42],0.8641136603966174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,16654,319,0.94 [0.75-1.17],0.5632531224136523
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,16557,317,0.92 [0.80-1.05],0.2029228832159861
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,14204,254,1.23 [0.88-1.70],0.2191928368716219
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,14613,264,1.14 [0.92-1.41],0.235916750353491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,16378,317,1.10 [0.94-1.29],0.2243029410371306
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,14583,261,1.16 [0.94-1.43],0.1685241007953243
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,16846,321,0.86 [0.73-1.03],0.1000606691212711
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,14613,264,0.95 [0.75-1.22],0.7058058768347142
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,16478,312,0.85 [0.70-1.04],0.1055264276858538
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,14658,262,1.16 [0.82-1.63],0.3997928261810114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,14613,264,0.86 [0.55-1.35],0.5250262773953234
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,14190,256,1.02 [0.81-1.29],0.8468998479100598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,16744,318,0.99 [0.86-1.14],0.9314020860356604
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,14373,259,0.97 [0.83-1.15],0.760550721238014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,14574,263,1.01 [0.91-1.12],0.8636439070683675
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,14169,257,0.94 [0.67-1.33],0.7364786004889374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,14169,257,0.90 [0.69-1.17],0.435745636305058
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,14373,259,1.07 [0.90-1.27],0.4672443314885154
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,14613,264,0.92 [0.61-1.39],0.6956601469243424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,14617,266,0.91 [0.65-1.27],0.5718609468519393
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,16705,317,0.96 [0.86-1.09],0.5445438326549596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,16913,324,1.10 [0.80-1.52],0.5511498415495448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,16402,318,0.96 [0.80-1.16],0.6726936333593051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,16326,312,1.34 [0.99-1.81],0.0560167645952126
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,16991,324,1.01 [0.80-1.28],0.9491101405753988
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,16913,324,1.28 [0.91-1.79],0.1559712173850601
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,16845,321,1.24 [0.93-1.67],0.1482462571609697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,16794,315,0.99 [0.74-1.33],0.95635215739344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,16786,315,1.03 [0.86-1.23],0.7514242730558625
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,14169,257,0.95 [0.63-1.43],0.8034826458369193
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,14339,253,1.64 [1.04-2.58],0.0320377080046686
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,16820,315,1.05 [0.94-1.18],0.3779066781846698
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,16485,311,1.34 [1.08-1.66],0.0083188146501599
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,14190,256,0.91 [0.77-1.09],0.3022458108580719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,16879,321,1.13 [0.91-1.39],0.2696410755314387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,14190,256,0.93 [0.72-1.21],0.6068840201614834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,14258,257,0.79 [0.50-1.24],0.2973349326795848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,14258,257,1.18 [0.86-1.60],0.2992839106131867
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,14190,256,0.83 [0.63-1.10],0.1987659872845085
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,14270,256,0.84 [0.63-1.12],0.2466386799158093
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,16426,308,1.01 [0.88-1.16],0.921368022562704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,14215,255,1.10 [0.86-1.40],0.4486961585686764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,14631,263,1.33 [0.89-1.97],0.1616490576539654
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,14270,256,1.12 [1.00-1.26],0.0515049966482787
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,16744,318,0.98 [0.81-1.17],0.8074575102028467
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SCT,Secretin,14258,257,1.08 [0.85-1.38],0.52602116803106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,16771,321,1.07 [0.83-1.37],0.6198160360175562
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,16771,321,0.95 [0.77-1.17],0.6419636324373659
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,14583,261,0.98 [0.88-1.09],0.7437904841022891
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,14571,263,0.85 [0.69-1.05],0.1383732079263915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,14339,253,0.94 [0.68-1.31],0.7315179584272683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,14270,256,0.96 [0.82-1.12],0.605038313350061
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,14270,256,1.13 [0.78-1.64],0.5166505534470076
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,16991,324,1.20 [0.99-1.46],0.063693695928665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,14658,262,1.14 [0.69-1.90],0.6012239147107435
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,14658,262,0.79 [0.47-1.34],0.3780166079939515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,16877,322,0.89 [0.75-1.07],0.2138345510027755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,16744,318,1.11 [0.76-1.62],0.5964835534437081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,16771,321,1.30 [0.90-1.88],0.1639918530100129
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,14339,253,1.15 [0.88-1.50],0.3005660315970092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,16705,317,0.95 [0.66-1.36],0.7833237668078102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,16913,324,0.97 [0.70-1.34],0.834571957446186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,14204,254,1.01 [0.63-1.62],0.9733381105617752
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,16953,324,1.09 [0.76-1.56],0.6379444666102855
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,14613,264,0.94 [0.80-1.10],0.4610099951581965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,14373,259,0.96 [0.76-1.20],0.6978367720472572
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,14596,264,0.95 [0.65-1.38],0.782404708790571
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,16705,317,1.08 [0.76-1.52],0.6691674455226068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,14359,258,2.02 [0.53-7.68],0.3006430100361065
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,16991,324,1.01 [0.80-1.29],0.9163724636844456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,16280,317,1.02 [0.92-1.13],0.7234131354798146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,14600,262,1.03 [0.47-2.26],0.9358338269549502
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,14378,261,0.79 [0.48-1.30],0.3498959749663669
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,14429,261,0.89 [0.59-1.34],0.590077075768386
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,14658,262,1.90 [0.90-4.05],0.094438288059858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,14658,262,0.82 [0.43-1.56],0.5431769723404565
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,16618,317,0.99 [0.86-1.15],0.925746318169164
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,16748,320,0.98 [0.87-1.09],0.6752841478448826
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,16478,312,0.85 [0.70-1.04],0.1213126907188168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,16857,324,1.04 [0.88-1.23],0.6522193756694263
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,16954,324,0.98 [0.82-1.16],0.79137980793092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,16635,316,0.87 [0.64-1.17],0.3509828971231309
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,14631,262,1.03 [0.46-2.31],0.9367180447080956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,14631,262,1.24 [0.81-1.88],0.3261813161628596
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,16991,324,0.97 [0.84-1.12],0.6568299303387525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,14631,263,1.02 [0.85-1.23],0.8117156369574048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,14425,260,1.23 [0.79-1.91],0.3673845094159693
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,14366,259,1.87 [0.77-4.55],0.1692316772677339
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,14631,262,1.23 [0.64-2.34],0.5306470569091531
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,14373,259,1.01 [0.92-1.11],0.8390248480808942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,14315,253,0.90 [0.59-1.38],0.6418155569617862
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,14571,263,1.27 [1.04-1.56],0.0201353455006028
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,16402,318,0.92 [0.79-1.08],0.31221959807124
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,16583,316,0.70 [0.50-1.00],0.0485087598596323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,14258,257,1.29 [0.89-1.88],0.1783669814689357
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,16846,321,1.22 [0.85-1.73],0.2791280118125104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,16705,317,0.86 [0.56-1.33],0.5059353396256059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,16705,317,0.92 [0.80-1.05],0.2244660957624407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,16585,315,1.00 [0.79-1.27],0.9723205924215198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,14339,253,1.08 [0.80-1.47],0.6140756737545463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,16426,308,1.12 [0.95-1.31],0.1924707651675319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,16426,308,0.93 [0.77-1.13],0.4885970044731575
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,16771,321,1.21 [1.05-1.40],0.0102101561027288
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,14366,261,1.28 [1.05-1.56],0.0162281832442186
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,16426,308,0.99 [0.90-1.10],0.9149951857678524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,16744,318,0.81 [0.67-0.99],0.0359256647452925
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,14190,256,0.93 [0.76-1.15],0.5088543138418681
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,14571,263,1.03 [0.81-1.30],0.8345892770249907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,14300,258,1.00 [0.86-1.15],0.959831815606248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,14621,264,0.87 [0.73-1.03],0.1126874868438184
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,14649,262,0.87 [0.68-1.11],0.2516570992895637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,14130,252,0.97 [0.87-1.08],0.5985098214814712
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,14136,256,0.95 [0.82-1.11],0.5268747604121038
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,14204,254,1.19 [0.91-1.54],0.2040720519578402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,14647,266,1.18 [0.76-1.83],0.4614407424365907
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",16820,315,0.93 [0.82-1.05],0.2243768756943302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,14373,259,0.94 [0.70-1.27],0.7041029339395042
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,16824,321,0.93 [0.75-1.16],0.5454050942108066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,16845,315,1.19 [0.93-1.51],0.1607586654968014
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,16744,318,1.09 [0.81-1.48],0.5591992126276066
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,16402,318,0.97 [0.84-1.11],0.6673331326432903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,16799,321,1.01 [0.93-1.10],0.7746902827562576
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,16938,322,1.07 [0.80-1.44],0.6493208468189746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,16771,321,1.18 [0.83-1.68],0.3588874778856949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,14270,256,1.16 [0.89-1.52],0.276182160336308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,16910,322,1.21 [0.86-1.69],0.2660489148654185
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,14270,256,1.15 [0.82-1.60],0.4236647004200957
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,16841,321,0.92 [0.77-1.08],0.3052407851320825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,16747,313,1.12 [0.91-1.38],0.2845750704059682
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,14204,254,1.02 [0.89-1.18],0.7539436062545146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,16705,317,0.92 [0.82-1.04],0.1750223606009351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",16402,318,1.18 [1.01-1.39],0.0419975472610953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,16485,311,1.09 [0.91-1.31],0.3393595466793848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,16606,316,0.96 [0.84-1.11],0.6000905365907125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,16845,315,0.97 [0.88-1.07],0.513601272658688
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,14169,257,1.04 [0.77-1.41],0.7881216131659372
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,14613,264,0.98 [0.88-1.10],0.7343649090954836
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,16485,311,1.22 [1.03-1.46],0.021970096265439
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,16426,308,1.04 [0.79-1.37],0.7650525860328542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,16744,318,0.95 [0.80-1.13],0.5592668912825901
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,16426,308,1.01 [0.83-1.22],0.9304033057378732
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,14169,257,0.89 [0.56-1.41],0.6151324579693771
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,14583,261,0.90 [0.72-1.13],0.3800564434562823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,16402,318,1.03 [0.87-1.23],0.7048457504418526
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,14258,257,1.01 [0.80-1.27],0.9521086154293594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,16402,318,1.02 [0.88-1.19],0.79301614587915
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,14130,252,0.94 [0.76-1.16],0.5614065856655672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,14130,252,1.18 [0.94-1.47],0.151398963545591
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,16402,318,1.02 [0.76-1.36],0.9171342923168252
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,16744,318,1.03 [0.85-1.25],0.756700541025962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,14258,257,1.05 [0.89-1.25],0.5397924735454138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,14647,266,0.70 [0.54-0.91],0.0076753125683043
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,14169,257,0.96 [0.81-1.14],0.6694949002937027
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,14339,253,0.97 [0.84-1.12],0.710322059882114
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,14571,263,1.04 [0.83-1.31],0.7458133645284001
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",14130,252,0.93 [0.74-1.17],0.5280824452430211
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,16402,318,0.91 [0.75-1.11],0.350961831215429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,14204,254,0.85 [0.58-1.24],0.3916251889840592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,16938,322,1.01 [0.79-1.30],0.9178028878276012
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,16478,312,0.96 [0.72-1.28],0.7784130699508275
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,14373,259,0.94 [0.80-1.11],0.4528618754520248
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,14571,263,1.02 [0.88-1.18],0.7862183710187107
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,14529,265,1.03 [0.75-1.42],0.8323596551095392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,16426,308,0.97 [0.86-1.09],0.5991981258810951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,14583,261,0.95 [0.80-1.13],0.5345100723134373
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,14583,261,0.92 [0.73-1.16],0.4863614115763623
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,16705,317,1.18 [0.70-1.97],0.5384774661735261
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,16402,318,1.05 [0.91-1.20],0.510304690324515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,14130,252,0.92 [0.72-1.17],0.4828906584003218
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,14571,263,0.95 [0.77-1.16],0.5910507971511951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,16938,322,1.25 [0.93-1.68],0.1456199643615137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,16845,315,1.15 [0.89-1.49],0.2731713371159606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,16825,323,0.96 [0.79-1.17],0.7057139466667397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,14204,254,1.09 [0.89-1.34],0.3932793009977506
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,16827,314,1.05 [0.91-1.23],0.4871773635413629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,14583,261,1.02 [0.88-1.19],0.7828932408917884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,14190,256,0.99 [0.81-1.20],0.878938580807864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,14604,264,1.01 [0.88-1.15],0.9308852943599888
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,16771,321,0.96 [0.86-1.08],0.5095752017227522
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,14190,256,1.00 [0.78-1.29],0.9971627926628128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,16846,321,0.96 [0.86-1.07],0.4226800367551713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,14613,264,0.99 [0.81-1.22],0.9289315157813458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,14339,253,0.92 [0.83-1.03],0.1362140765008756
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,16635,316,0.98 [0.85-1.14],0.8142703671147997
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",14270,256,1.04 [0.72-1.50],0.8460351915042481
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',14621,264,1.00 [0.77-1.30],0.984385269268128
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,14169,257,1.03 [0.85-1.25],0.7449528215429717
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,14339,253,0.87 [0.69-1.10],0.2449024600666794
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,14571,263,0.99 [0.75-1.30],0.9168653738744166
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,14583,261,1.00 [0.87-1.15],0.9604306361931444
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,14270,256,0.67 [0.43-1.04],0.0765612979070892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,16771,321,0.95 [0.82-1.11],0.5411246061897692
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],16489,311,0.74 [0.59-0.92],0.0059024039271486
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",16799,321,1.06 [0.81-1.37],0.6795845365545446
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,14649,262,0.91 [0.73-1.13],0.3867367034173511
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,14613,264,1.16 [0.90-1.50],0.2489566221173971
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,16426,308,1.18 [0.89-1.57],0.24190376792923
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,16853,319,0.97 [0.84-1.12],0.6797910933877802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,16745,321,0.99 [0.76-1.30],0.9664324164009224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,16745,321,1.01 [0.78-1.30],0.9316439644036256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,14258,257,0.95 [0.74-1.22],0.6961053187490056
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,14583,263,0.89 [0.53-1.47],0.6425373057624144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,14258,257,1.09 [0.70-1.71],0.6983103884237137
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,14613,264,0.84 [0.55-1.27],0.4089212087074358
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,14613,264,0.88 [0.70-1.10],0.2550332841323889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,16846,321,0.94 [0.82-1.08],0.4097368261992733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,16821,322,0.84 [0.59-1.21],0.359156926399821
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPART,Spartin,14339,253,0.99 [0.84-1.16],0.8543690611120415
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,14631,263,1.39 [0.99-1.94],0.0558129451688831
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,16799,321,1.36 [1.09-1.69],0.0059899501824902
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,14339,253,0.99 [0.70-1.39],0.9439117288459962
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,16744,318,1.03 [0.89-1.20],0.6484308672890542
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,16799,321,1.09 [0.82-1.45],0.5554258686751068
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,16938,322,1.12 [0.93-1.36],0.2348917804924823
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,14169,257,0.76 [0.52-1.12],0.1651469914857559
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,16755,320,1.13 [0.76-1.68],0.5598837184346801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,16845,315,1.09 [0.85-1.41],0.4875043490122408
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,14571,263,0.98 [0.91-1.06],0.5837432677051663
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,16635,316,0.84 [0.57-1.23],0.3686460273941873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,16794,315,1.29 [0.95-1.74],0.1017009659835133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,16704,321,1.09 [0.82-1.46],0.5343766843011881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,16968,323,1.24 [1.00-1.55],0.0488633222738678
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",14204,254,1.19 [0.90-1.57],0.2174799594625323
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,14130,252,1.03 [0.85-1.25],0.7779496103105955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,14373,259,1.06 [0.92-1.21],0.4342892341457803
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,14621,264,0.82 [0.68-0.98],0.0325273002361007
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,16485,311,1.01 [0.90-1.12],0.8927727278921098
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",14190,256,0.92 [0.63-1.35],0.6769507175242488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,14621,264,0.91 [0.66-1.27],0.5891075589337731
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,16817,321,0.98 [0.91-1.07],0.7175818012860338
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,16705,317,0.90 [0.76-1.06],0.1964837764381723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,16744,318,0.98 [0.86-1.10],0.7004736898249864
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,14631,263,0.91 [0.67-1.23],0.5315508476374295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,16402,318,0.90 [0.75-1.08],0.2629515516303985
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",14204,254,1.13 [0.81-1.58],0.4762876473121914
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,16745,321,1.02 [0.94-1.11],0.5825496256554845
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,16877,322,1.12 [0.88-1.41],0.3511842693647622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,14130,252,1.15 [0.77-1.73],0.4959429728901459
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,14571,263,1.03 [0.82-1.30],0.7714069504276729
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,14339,253,0.82 [0.65-1.01],0.0670835689813713
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",16705,317,1.03 [0.81-1.30],0.8299575967853374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",16991,324,1.12 [0.82-1.54],0.4671464246411319
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",14204,254,0.94 [0.72-1.22],0.6324319560161458
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,14647,266,1.45 [0.95-2.21],0.0849200131607478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,14583,261,0.74 [0.52-1.06],0.1005413979655687
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,16606,316,0.93 [0.79-1.09],0.3429415682901464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,14204,254,1.01 [0.86-1.18],0.9500316280651414
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,16705,317,0.98 [0.91-1.05],0.4946810331222919
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,14130,252,0.95 [0.78-1.15],0.6039995418389436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,16913,324,1.21 [0.97-1.50],0.0887924619401955
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,16781,320,1.30 [0.85-1.98],0.2226319921946053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,14190,256,0.96 [0.80-1.14],0.6126873037457019
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,16776,320,0.87 [0.74-1.02],0.0770828946320453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,16478,312,0.88 [0.77-1.02],0.0834915957358491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,16402,318,0.97 [0.82-1.14],0.6885262937659742
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,16771,321,1.00 [0.89-1.12],0.95778420519895
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",14130,252,1.06 [0.94-1.21],0.3382949789067094
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,16426,308,1.03 [0.86-1.23],0.7529493593044391
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,14258,257,1.03 [0.77-1.38],0.8510314718710792
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,14621,264,1.00 [0.74-1.35],0.989437319534005
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,16705,317,1.00 [0.85-1.19],0.9699105134416488
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,14204,254,1.33 [1.06-1.68],0.0155751759697585
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,16426,308,0.98 [0.83-1.15],0.7586742617281125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,14204,254,0.81 [0.63-1.04],0.0918788788945829
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,16744,318,0.97 [0.79-1.20],0.8115555296158437
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,14613,264,0.94 [0.80-1.09],0.3900853830912913
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,16426,308,0.88 [0.69-1.13],0.3175562479664485
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,14571,263,1.04 [0.77-1.40],0.8045753867892146
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,16426,308,0.93 [0.82-1.06],0.2920425330569646
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,16913,324,0.99 [0.92-1.07],0.7796343377619868
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,16744,318,1.09 [0.92-1.29],0.3016716130372709
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,14204,254,1.03 [0.86-1.24],0.749518292603405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,16913,324,0.98 [0.81-1.19],0.8585004737275428
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",14613,264,1.07 [0.89-1.29],0.4792768621445233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,16478,312,0.90 [0.73-1.10],0.314797438165665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,16799,321,1.22 [0.87-1.72],0.2413373835139933
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,14583,261,1.13 [0.86-1.49],0.3879023791098648
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,14262,253,0.94 [0.66-1.34],0.721221324150016
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,14258,257,0.88 [0.71-1.08],0.214849496877491
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,14571,263,0.95 [0.68-1.33],0.7673830965045199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,14339,253,0.91 [0.73-1.13],0.4086005409262949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,14190,256,0.84 [0.67-1.07],0.153889960704202
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,14621,264,1.00 [0.76-1.33],0.9738354101464402
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,14631,263,1.00 [0.85-1.18],0.9687416547635842
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,14373,259,0.99 [0.88-1.11],0.8195781271478699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,16705,317,0.99 [0.91-1.08],0.8431565350835979
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,14894,284,1.64 [1.16-2.33],0.0052579765114387
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,14583,261,0.90 [0.67-1.22],0.4971248466688285
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,16705,317,1.03 [0.79-1.35],0.807791783680301
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,14130,252,0.96 [0.78-1.18],0.6908495146494664
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,14586,266,0.85 [0.65-1.13],0.2636731769134529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,16485,311,1.03 [0.89-1.19],0.7120320610878881
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,14373,259,1.06 [0.88-1.29],0.5378460188821366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,16402,318,0.97 [0.85-1.10],0.591391579192893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",14258,257,1.07 [0.92-1.24],0.3928303789180345
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",14583,261,0.82 [0.60-1.14],0.2390233335815637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,14621,264,1.04 [0.86-1.26],0.6986173855854434
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,16402,318,0.90 [0.71-1.13],0.3594187181475778
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,16705,317,0.96 [0.85-1.07],0.4227775942069216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,16744,318,0.94 [0.83-1.08],0.3901310522781405
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,14339,253,0.90 [0.78-1.05],0.1747769011952924
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,16635,316,0.95 [0.86-1.04],0.2705876655572942
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,16635,316,0.94 [0.83-1.06],0.3136225107705267
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,16426,308,1.02 [0.91-1.15],0.693944969588555
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,14258,257,0.93 [0.71-1.21],0.5817324992746746
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,16618,316,0.94 [0.85-1.04],0.2366098122685672
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,16478,312,1.00 [0.88-1.13],0.97785360558168
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,14339,255,1.17 [0.84-1.64],0.3564279158557071
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,16968,323,1.07 [0.78-1.47],0.6627517454526843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,14631,263,1.17 [0.81-1.69],0.3967871509358305
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,14373,259,0.93 [0.74-1.16],0.5098113226742413
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,14631,263,1.63 [1.10-2.40],0.0142274117121725
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,16402,318,1.02 [0.96-1.09],0.530324577075637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",14258,257,1.05 [0.77-1.43],0.7412403391257751
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,14583,261,0.97 [0.82-1.15],0.7377730468675037
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,16402,318,0.97 [0.86-1.10],0.6548962856520013
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,14169,257,1.14 [0.88-1.48],0.310665005388764
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,16846,321,1.23 [0.78-1.92],0.3734658278134949
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,14204,254,1.22 [0.81-1.84],0.3432966672489704
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,14337,259,0.92 [0.81-1.05],0.2385206828271909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,14258,257,0.97 [0.79-1.19],0.7687946777543633
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,14373,259,0.90 [0.64-1.25],0.5265833381040903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,14658,262,0.75 [0.44-1.30],0.3059914356985548
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,14190,256,0.94 [0.77-1.15],0.5501381923345929
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,16723,320,1.10 [0.98-1.23],0.1156165983297539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,16820,315,1.15 [0.97-1.36],0.107752516962379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,16789,322,1.26 [1.01-1.59],0.0433765938516133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,16778,321,1.02 [0.73-1.41],0.9168741057334954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,16803,321,1.23 [0.99-1.52],0.0575502938427067
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,16870,321,0.87 [0.67-1.13],0.2906888390294427
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,14583,261,1.01 [0.91-1.12],0.8595054694085178
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,16744,318,1.10 [0.89-1.36],0.3939655162237697
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,16928,323,0.98 [0.75-1.27],0.8618382075588533
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,14583,261,1.19 [0.97-1.46],0.1011932639786199
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,16720,320,1.07 [0.74-1.54],0.7300819401198674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,14204,254,1.32 [0.79-2.23],0.2921335807439727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,16846,321,1.17 [0.88-1.56],0.2721641087079802
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,16991,324,1.01 [0.73-1.38],0.9682362961066908
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,16752,321,0.88 [0.77-1.00],0.0490299687741556
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,14649,262,1.03 [0.67-1.60],0.883251882830419
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,14108,252,1.08 [0.95-1.23],0.2443467806515739
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,16771,321,1.20 [0.86-1.66],0.2865860952929602
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,16799,321,1.26 [0.98-1.62],0.0681182275247429
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,16816,321,1.01 [0.81-1.26],0.9220161397502348
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,16683,320,0.84 [0.60-1.17],0.3010611407614254
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,16478,312,0.97 [0.75-1.25],0.8044241573236535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,14169,257,1.07 [0.96-1.18],0.2073518408838059
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,14090,252,1.12 [0.79-1.60],0.5245212736864365
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,14558,261,0.88 [0.77-1.01],0.0786305624585092
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,16913,324,1.30 [0.93-1.81],0.1210365609740233
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,16297,310,0.97 [0.89-1.05],0.4592179233613592
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,16991,324,0.95 [0.76-1.20],0.6739765839797597
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",16373,318,0.94 [0.76-1.18],0.600711912297366
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,14373,259,0.77 [0.54-1.08],0.1320302838852463
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16877,322,1.09 [0.87-1.37],0.4679018965885998
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,14631,263,1.07 [0.80-1.44],0.6353361733332468
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,14621,264,0.99 [0.86-1.14],0.9222562026739144
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,16643,319,1.25 [0.88-1.77],0.2052878064188644
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,14631,263,0.56 [0.32-0.98],0.0412736868395665
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,16845,315,0.97 [0.90-1.05],0.4859592663327674
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,16799,321,0.79 [0.61-1.01],0.0629051707505152
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,16721,321,1.38 [0.88-2.16],0.159824317326174
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,16846,321,0.97 [0.86-1.09],0.5968515914238489
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,14190,256,0.74 [0.54-1.02],0.0698937576118965
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",14373,259,0.96 [0.73-1.26],0.7518351786133086
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,14204,254,1.48 [0.96-2.29],0.0785507911268479
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,14373,259,1.14 [0.68-1.91],0.6206764547522552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,16954,324,1.03 [0.88-1.21],0.7042014642200396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,14204,254,1.67 [1.14-2.44],0.0089918014030157
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,14258,257,0.87 [0.69-1.10],0.2480920542628351
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,14373,259,0.99 [0.80-1.23],0.9198330057882989
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,14169,257,0.97 [0.74-1.28],0.8426500517559801
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,14169,257,1.10 [0.91-1.34],0.3079886009355921
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,14571,263,0.96 [0.85-1.07],0.4401738928642125
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,14583,261,0.94 [0.79-1.12],0.4889394242332516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,14270,256,1.05 [0.87-1.28],0.5889320674790854
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,14613,264,0.92 [0.70-1.20],0.527381850365467
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,14130,252,1.01 [0.74-1.37],0.9588019027081884
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,14190,256,1.00 [0.85-1.17],0.9745131634044026
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,14596,264,1.29 [0.98-1.71],0.0715318180004051
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,16705,317,1.12 [1.00-1.24],0.0483083722822649
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,16563,316,1.07 [0.83-1.39],0.597220722193629
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,16799,321,0.95 [0.83-1.09],0.4781178827996551
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,16877,322,0.95 [0.78-1.17],0.6431189085241961
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,16453,312,1.03 [0.78-1.35],0.8468279709813371
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,14571,263,1.01 [0.79-1.30],0.9167053896074396
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,16485,311,1.00 [0.76-1.32],0.9784567329256044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,14339,253,0.98 [0.80-1.19],0.8158546112487106
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,16635,316,0.98 [0.72-1.34],0.9162699022994134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,16635,316,1.24 [1.06-1.45],0.0085499586683494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,16830,320,0.88 [0.72-1.07],0.2066417123331369
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,16954,324,1.44 [1.14-1.82],0.0023241059837853
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,16765,314,1.38 [0.99-1.94],0.0593454977907873
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,16846,321,1.19 [0.91-1.57],0.2059894398499594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16794,315,1.16 [0.86-1.57],0.3339710276205334
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,16485,311,1.02 [0.79-1.31],0.8923869972085964
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,16794,315,1.14 [0.82-1.57],0.4396328498536552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,14339,253,0.94 [0.70-1.26],0.6893466156574448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,16938,322,1.11 [0.83-1.49],0.4878877337314147
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16799,321,1.28 [0.94-1.74],0.1178249194012898
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16799,321,1.20 [0.95-1.53],0.1283880874582719
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,16913,324,1.22 [0.86-1.73],0.2618460411574783
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16928,323,1.26 [0.98-1.62],0.0699347371172518
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,16635,316,1.20 [1.01-1.41],0.0355813119038892
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16913,324,1.10 [0.88-1.37],0.399813868382723
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,16635,316,1.19 [0.94-1.52],0.149717653314048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,16954,324,1.07 [0.73-1.57],0.7324466133329817
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,16744,318,0.88 [0.74-1.03],0.1160386114178214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,16954,324,0.81 [0.57-1.15],0.2335105031714477
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,16845,315,1.12 [0.77-1.63],0.5486114401620368
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,16971,324,1.44 [1.02-2.02],0.0356839562947473
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,16635,316,0.99 [0.83-1.18],0.9175068590999216
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,14647,266,0.96 [0.69-1.33],0.8129539501283897
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,14621,264,0.99 [0.86-1.13],0.8517088701561514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,14647,266,0.98 [0.75-1.28],0.8884431857915636
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",16478,312,1.12 [0.99-1.27],0.0760499014742273
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,14373,259,0.97 [0.69-1.38],0.8810423638822363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,16635,316,0.92 [0.73-1.17],0.5125172675183516
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,16799,321,0.73 [0.49-1.07],0.1029640075292448
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,14631,263,0.98 [0.84-1.14],0.7641624409163525
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,14571,263,1.01 [0.91-1.11],0.9099175783540296
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",14130,252,0.96 [0.74-1.24],0.7517557301213277
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,14204,254,0.96 [0.82-1.13],0.6342546262103843
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,14270,256,0.93 [0.73-1.18],0.5265126845453102
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,16426,308,1.14 [0.90-1.44],0.2739140636317647
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,14204,254,0.87 [0.75-1.01],0.0716865536588412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,14026,248,1.07 [0.84-1.36],0.5724337997689302
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,16478,312,1.11 [0.82-1.52],0.492922074911637
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,14258,257,0.95 [0.66-1.35],0.7675835327154494
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,14258,257,0.93 [0.69-1.25],0.6371038570233876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,14339,253,0.95 [0.85-1.06],0.3257843568150053
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,14631,263,0.80 [0.52-1.23],0.3101943463256984
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,14169,257,1.21 [0.95-1.54],0.1175146626306064
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,16426,308,0.91 [0.79-1.05],0.2116794232149834
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,16656,313,1.07 [0.86-1.33],0.5523815554458346
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,14373,259,1.04 [0.90-1.20],0.5711379736933374
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,16402,318,0.96 [0.74-1.25],0.7680384090243453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,14169,257,0.90 [0.69-1.18],0.4321914755285203
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,14130,252,1.02 [0.85-1.21],0.8565362869679543
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,16931,324,1.09 [0.90-1.32],0.3584498260855057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,14613,264,1.04 [0.77-1.42],0.781592887135081
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,14204,254,1.59 [1.05-2.40],0.0285097146786808
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,16485,311,1.13 [1.00-1.29],0.0551819710452883
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,16744,318,0.91 [0.79-1.05],0.2043178811825192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",14204,254,0.99 [0.71-1.37],0.933990015082392
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,14169,257,0.85 [0.64-1.12],0.2535887121517063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,14373,259,0.92 [0.79-1.06],0.2262615894784514
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,14647,266,1.03 [0.88-1.20],0.7487595971161388
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,16765,314,1.12 [0.93-1.35],0.2462488034108749
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,14649,262,1.03 [0.82-1.29],0.8045323151626632
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,16799,321,1.01 [0.75-1.35],0.9449976083994224
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,16938,322,0.92 [0.78-1.09],0.3318946127783133
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,16744,318,0.92 [0.81-1.05],0.2210376321413747
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,14349,259,1.04 [0.87-1.25],0.6824590485330999
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,14571,263,1.01 [0.90-1.13],0.8896610943637084
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,14130,252,1.03 [0.84-1.28],0.7543194592077695
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,14258,257,1.02 [0.87-1.21],0.7747610875332105
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,16744,318,1.04 [0.93-1.17],0.497027218739228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,14583,261,0.97 [0.85-1.11],0.6661702497716706
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,14169,257,1.03 [0.81-1.31],0.8142095738158327
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,14204,254,1.04 [0.89-1.23],0.5962788781022699
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,14613,264,0.99 [0.83-1.19],0.9425705278364622
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,16771,321,0.98 [0.86-1.12],0.782714509514828
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,16478,312,0.97 [0.81-1.15],0.6860793377712143
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,14169,257,0.89 [0.65-1.22],0.4760527705924594
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,16478,312,1.10 [0.98-1.22],0.0956244730690308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,14169,257,0.93 [0.73-1.19],0.5651276946460889
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,14190,256,1.00 [0.88-1.13],0.962688547355848
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,14571,263,1.03 [0.91-1.17],0.6127305741700262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,14204,254,0.91 [0.66-1.25],0.5708446977327103
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,16365,317,0.96 [0.84-1.10],0.5997782545247009
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,14258,257,1.09 [0.85-1.39],0.5085264619164733
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTN,Titin,14169,257,1.21 [1.03-1.41],0.0167426078263579
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,14502,262,0.98 [0.61-1.58],0.932859961308324
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,14190,256,0.87 [0.56-1.33],0.5106298956131364
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,14647,266,0.93 [0.81-1.07],0.328069426985951
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,14373,259,0.95 [0.80-1.12],0.5183257062986484
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,16635,316,1.00 [0.89-1.12],0.9646591557784286
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,14402,256,0.80 [0.59-1.08],0.1410276643755893
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,16846,321,1.05 [0.73-1.51],0.7824493882181909
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,16913,324,1.01 [0.87-1.17],0.8806216867799163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,14621,264,1.01 [0.81-1.27],0.9147650348890876
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,14162,254,1.03 [0.91-1.16],0.6535058793302255
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",16799,321,0.89 [0.71-1.11],0.2919952975862447
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,16661,320,0.95 [0.81-1.10],0.4817304112654859
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,16771,321,0.92 [0.65-1.30],0.6392016874391954
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",14204,254,1.04 [0.86-1.25],0.7144442023850226
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,16705,317,0.70 [0.53-0.94],0.0192592072509478
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,14583,261,0.82 [0.54-1.25],0.36313978036266
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,14631,263,0.93 [0.77-1.14],0.5010788912554057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,14204,254,1.05 [0.85-1.29],0.6754753099237552
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,14169,257,0.91 [0.72-1.14],0.4085264716564091
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,14339,253,0.90 [0.75-1.09],0.277884023690973
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,14571,263,0.96 [0.88-1.05],0.3903693338298631
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,14169,257,0.99 [0.87-1.12],0.859264286656134
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,14169,257,0.99 [0.70-1.40],0.9733149322828192
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,16635,316,1.18 [0.91-1.52],0.2075120379939981
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,16947,322,0.96 [0.80-1.15],0.6388997080286268
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,14204,254,1.11 [0.69-1.77],0.6760346434080214
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,14130,252,1.09 [0.88-1.36],0.4179120351545875
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,14583,261,0.91 [0.65-1.29],0.6090098819224241
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,14631,263,1.05 [0.92-1.20],0.5072601744198375
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,14190,256,1.10 [0.88-1.39],0.4065446774691837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,14342,258,0.96 [0.76-1.21],0.719989665209138
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,14339,253,0.90 [0.75-1.08],0.2643933126177057
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,14258,257,0.98 [0.82-1.18],0.8290498734464063
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,16705,317,0.94 [0.84-1.05],0.2713199086492946
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,14583,261,0.95 [0.80-1.13],0.5547154926283426
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,14621,264,1.16 [0.86-1.57],0.3194513764837245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,14169,257,0.87 [0.75-1.02],0.0914592471444308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,16478,312,0.95 [0.85-1.06],0.3461863732096825
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,16426,308,0.99 [0.81-1.20],0.8835739124010917
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,16478,312,0.85 [0.68-1.05],0.1282887050187256
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,14204,254,0.96 [0.83-1.10],0.5547073998054515
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,16744,318,0.98 [0.86-1.10],0.7001661416289975
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,16535,316,1.06 [0.73-1.53],0.7621389860677926
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,14649,262,0.96 [0.81-1.13],0.6148949862041567
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,16705,317,0.45 [0.27-0.76],0.002624613880782
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,14190,256,0.99 [0.88-1.12],0.9005298735670724
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,16846,321,1.10 [0.76-1.59],0.613949755200806
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,16913,324,1.19 [0.86-1.65],0.2888704885323878
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,14130,252,1.02 [0.89-1.17],0.7990637685838407
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,16909,324,1.03 [0.87-1.22],0.7457861022126842
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,14204,254,0.83 [0.54-1.26],0.381564492888175
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,16846,321,0.90 [0.76-1.08],0.2509853565879757
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,16927,324,1.03 [0.80-1.34],0.8018908689141424
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,14613,264,0.86 [0.58-1.26],0.4270337743654399
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,16478,312,0.90 [0.83-0.97],0.0071862044168539
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,14270,256,0.65 [0.38-1.12],0.1244091498004406
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,14631,263,1.13 [0.82-1.54],0.4537503391652815
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,16705,317,1.21 [1.04-1.41],0.0161035000038606
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,14649,262,1.00 [0.85-1.18],0.9603367423846436
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,16705,317,0.91 [0.74-1.13],0.3968085490884313
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,14373,259,0.95 [0.79-1.14],0.5883906882446535
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,16705,317,1.04 [0.92-1.18],0.5538063102623453
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,14583,261,0.94 [0.82-1.06],0.3114132618800454
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,16705,317,1.00 [0.87-1.13],0.9398450643380524
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,14583,261,1.05 [0.74-1.49],0.7831329509513412
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,14169,257,1.01 [0.70-1.45],0.9673197737850044
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,14583,261,1.20 [1.02-1.41],0.0313783755335198
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,16781,320,1.10 [0.87-1.39],0.4074935362019457
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,16741,320,1.00 [0.85-1.18],0.9761447179429228
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,14621,264,1.13 [0.83-1.53],0.4478906721007205
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,16402,318,0.98 [0.81-1.19],0.8649233500545546
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,14373,259,0.88 [0.65-1.20],0.4318699535993173
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,16478,312,0.91 [0.76-1.09],0.3203413615353456
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,16913,324,0.93 [0.81-1.06],0.2789866025937163
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,16426,308,1.09 [0.78-1.52],0.6126329252023972
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,14339,253,0.89 [0.72-1.12],0.3278330566265927
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,16907,321,1.06 [0.84-1.35],0.6046410833772455
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,14130,252,0.90 [0.76-1.07],0.2457072835845956
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,16578,316,1.08 [0.84-1.38],0.5340455307447343
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,14613,264,0.77 [0.56-1.05],0.0971255473577464
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,16991,324,1.08 [0.95-1.24],0.2356230703589529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",16799,321,0.85 [0.66-1.11],0.237311275675404
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,16485,311,0.98 [0.84-1.15],0.8077387457836837
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,16478,312,0.96 [0.86-1.07],0.478257079294379
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,16402,318,0.99 [0.88-1.12],0.8809510570493563
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,14621,264,0.98 [0.84-1.15],0.8316820681164422
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,14204,254,1.05 [0.86-1.27],0.6578422738659075
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,14583,261,0.76 [0.53-1.10],0.1491862642057245
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,14274,257,0.94 [0.74-1.19],0.5896109993057977
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,16916,321,0.89 [0.76-1.05],0.1607264704796397
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,15956,300,1.34 [1.06-1.70],0.0139161681102683
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",16583,316,1.02 [0.80-1.29],0.8903119472918344
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",16794,315,1.00 [0.75-1.34],0.9917961282907048
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,16938,322,0.76 [0.57-1.02],0.0662057747462363
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,16485,311,0.90 [0.64-1.28],0.5617594535874183
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,16635,316,0.94 [0.78-1.14],0.5548332578058529
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,16938,322,1.01 [0.85-1.22],0.8815464737574745
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,16917,324,1.10 [0.82-1.48],0.5329554461005896
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,14204,254,1.03 [0.83-1.27],0.8146992939644295
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,16846,321,1.04 [0.95-1.15],0.3914241104945378
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,16402,318,0.94 [0.71-1.23],0.6495613749511127
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,14621,264,0.96 [0.62-1.49],0.8661054693312598
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",14571,263,0.95 [0.88-1.03],0.2444765600142356
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,16705,317,1.03 [0.94-1.12],0.5508298973411141
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,14583,261,0.83 [0.57-1.22],0.3545049285987104
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,14169,257,0.82 [0.67-1.00],0.0458301271904561
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,16485,311,0.96 [0.85-1.08],0.460015947926953
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,14339,253,0.97 [0.82-1.15],0.7131467813918315
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,14204,254,1.19 [0.78-1.83],0.420476946275079
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,14204,254,1.09 [0.80-1.49],0.5898443432989262
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,16426,308,1.03 [0.89-1.18],0.6948787755112308
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,16478,312,0.82 [0.62-1.07],0.1429012156442727
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,14169,257,0.89 [0.72-1.11],0.3112850786463605
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,14571,263,0.91 [0.80-1.04],0.1670571782082557
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,14621,264,0.91 [0.61-1.35],0.6463117637076022
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,14204,254,0.96 [0.69-1.35],0.8321206159709023
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,14373,259,1.04 [0.86-1.25],0.7058457743353903
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,14583,261,0.97 [0.83-1.14],0.7354723378054899
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,14571,263,1.04 [0.88-1.23],0.6412952092173849
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,14583,261,0.99 [0.79-1.23],0.8996172671286858
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,14270,256,0.97 [0.93-1.01],0.1870193405104755
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,14130,252,1.04 [0.72-1.50],0.8256773095869839
Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,14190,256,1.02 [0.90-1.15],0.806139682842332
